+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 58974

Chapter 58974 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Zhu, J.; Djukovic, D.; Deng, L.; Gu, H.; Himmati, F.; Abu Zaid, M.; Chiorean, E.Gabriela.; Raftery, D., 2016:
Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring

Zhang, W.; Müller, K.; Kessel, E.; Reinhard, Sören.; He, D.; Klein, P.M.; Höhn, M.; Rödl, W.; Kempter, S.; Wagner, E., 2016:
Targeted siRNA Delivery Using a Lipo-Oligoaminoamide Nanocore with an Influenza Peptide and Transferrin Shell

MacVicar, T.D.B.; Mannack, L.V.J.C.; Lees, R.M.; Lane, J.D., 2016:
Targeted siRNA Screens Identify ER-to-Mitochondrial Calcium Exchange in Autophagy and Mitophagy Responses in RPE1 Cells

Hsu, F.Y.; Anderson, W.F.; Johnston, P.B., 2016:
Targeted siRNA inhibition of NPM-ALK in anaplastic large cell lymphoma causes disease specific growth inhibition which augments chemotherapeutic agents

Han, K-Qi.; He, X-Qun.; Ma, M-Yu.; Guo, X-Dong.; Zhang, X-Min.; Chen, J.; Han, H.; Zhang, W-Wei.; Zhu, Q-Gang.; Zhao, W-Zhao., 2016:
Targeted silencing of CXCL1 by siRNA inhibits tumor growth and apoptosis in hepatocellular carcinoma

Duan, Y.; Zhang, S.; Wang, L.; Zhou, X.; He, Q.; Liu, S.; Yue, K.; Wang, X., 2016:
Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma

Unsoy, G.; Gunduz, U., 2017:
Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles

Hussein, H.E.; Scoles, G.A.; Ueti, M.W.; Suarez, C.E.; Adham, F.K.; Guerrero, F.D.; Bastos, R.G., 2016:
Targeted silencing of the Aquaporin 2 gene of Rhipicephalus (Boophilus) microplus reduces tick fitness

Willmore, A-Mari.A.; Simón-Gracia, L.; Toome, K.; Paiste, Päärn.; Kotamraju, V.Ramana.; Mölder, T.; Sugahara, K.N.; Ruoslahti, E.; Braun, G.B.; Teesalu, T., 2015:
Targeted silver nanoparticles for ratiometric cell phenotyping

Gregory, M.T.; Bertout, J.A.; Ericson, N.G.; Taylor, S.D.; Mukherjee, R.; Robins, H.S.; Drescher, C.W.; Bielas, J.H., 2016:
Targeted single molecule mutation detection with massively parallel sequencing

Orkunoglu-Suer, F.; Harralson, A.F.; Frankfurter, D.; Gindoff, P.; O'Brien, T.J., 2015:
Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome

Janzen, S.A.; Jensen, N.D.; Mude, A.G., 2016:
Targeted social protection in a pastoralist economy: case study from Kenya

Chong, L.X.; Turpin, A.; McKendrick, A.M., 2015:
Targeted spatial sampling using GOANNA improves detection of visual field progression

Ndagije, H.; Nambasa, V.; Namagala, E.; Nassali, H.; Kajungu, D.; Sematiko, G.; Olsson, S.; Pal, S., 2016:
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda

Buckley, U.; Yamakawa, K.; Takamiya, T.; Andrew Armour, J.; Shivkumar, K.; Ardell, J.L., 2016:
Targeted stellate decentralization: Implications for sympathetic control of ventricular electrophysiology

Pavey, G.J.; Qureshi, A.T.; Tomasino, A.M.; Honnold, C.L.; Bishop, D.K.; Agarwal, S.; Loder, S.; Levi, B.; Pacifici, M.; Iwamoto, M.; Potter, B.K.; Davis, T.A.; Forsberg, J.A., 2017 :
Targeted stimulation of retinoic acid receptor-γ mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model

Bublak, R., 2016:
Targeted strengthening of hamstring weak areas

Jose, J.; Al-Tamimi, F.Abdullah.Ali.; Helal, M.Mahmoud.; Jimmy, B.; A.R.yami, Q.; A.B.saidi, I., 2016:
Targeted study to evaluate the cardiovascular risk factor status among patients and efficacy of statins in attaining goal lipid levels in a regional hospital in Sultanate of Oman

Bakhtiary, Z.; Saei, A.Ata.; Hajipour, M.J.; Raoufi, M.; Vermesh, O.; Mahmoudi, M., 2015:
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges

Monteiro, F.; Bernal, V.; Chaillet, M.; Berger, I.; Alves, P.M., 2016:
Targeted supplementation design for improved production and quality of enveloped viral particles in insect cell-baculovirus expression system

Sarwar, M.; Semenas, J.; Miftakhova, R.; Simoulis, A.; Robinson, B.; Gjörloff Wingren, A.; Mongan, N.P.; Heery, D.M.; Johnsson, H.; Abrahamsson, P-Anders.; Dizeyi, N.; Luo, J.; Persson, J.L., 2016:
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells

Doherr, M.G.; Oesch, B.; Moser, M.; Vandevelde, M.; Heim, D., 2015:
Targeted surveillance for bovine spongiform encephalopathy

Hamilton, A.; Richter, S., 2015:
Targeted survey as a method to rationalize priorities for a strategy to improve eye health in rural Uganda

Ding, H.; Yang, Y.; Li, B.; Pan, F.; Zhu, G.; Zeller, M.; Yuan, D.; Wang, C., 2015:
Targeted synthesis of a large triazine-based [4+6] organic molecular cage: structure, porosity and gas separation

Mikolasch, A.; Hildebrandt, O.; Schlüter, R.; Hammer, E.; Witt, S.; Lindequist, U., 2016:
Targeted synthesis of novel β-lactam antibiotics by laccase-catalyzed reaction of aromatic substrates selected by pre-testing for their antimicrobial and cytotoxic activity

Yi, Y.; Kim, H.Jin.; Mi, P.; Zheng, M.; Takemoto, H.; Toh, K.; Kim, B.Soo.; Hayashi, K.; Naito, M.; Matsumoto, Y.; Miyata, K.; Kataoka, K., 2016:
Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles

Kim, Y.Seop.; Kong, W.Ho.; Kim, H.; Hahn, S.Kwang., 2017:
Targeted systemic mesenchymal stem cell delivery using hyaluronate - wheat germ agglutinin conjugate

Grunau, B.E.; Christenson, J.; Brooks, S.C., 2015:
Targeted temperature management after out-of-hospital cardiac arrest: who, when, why, and how?

Taccone, F.Silvio.; Colpaert, K.; D.W.ele, J.; D.W.erdt, A.; Hermans, G.; Ledoux, D.; Meyfroidt, G.; Michaux, I.; Sottiaux, T.; Wittebole, X., 2016:
Targeted temperature management and neuroprognostication after cardiac arrest: A survey in Belgium

Murata, S.; Kashiwagi, M.; Tanabe, T.; Oba, C.; Shigehara, S.; Yamazaki, S.; Ashida, A.; Sirasu, A.; Inoue, K.; Okasora, K.; Tamai, H., 2015:
Targeted temperature management for acute encephalopathy in a Japanese secondary emergency medical care hospital

Fukuda, T., 2016:
Targeted temperature management for adult out-of-hospital cardiac arrest: current concepts and clinical applications

Tripathy, S.; Mahapatra, A.Kumar., 2015:
Targeted temperature management in brain protection: An evidence-based review

Gorecka, M.; Hanley, A.; Burke, F.; Nolan, P.; Crowley, J., 2016:
Targeted temperature management in cardiovascular disease complicated by cardiac arrest

Hunter, B.R.; Ellender, T.J., 2015:
Targeted temperature management in emergency medicine: current perspectives

Yokobori, S.; Yokota, H., 2016:
Targeted temperature management in traumatic brain injury

Aygencel, Gülbin., 2016:
Targeted temperature management, or therapeutic hypothermia, in post-resuscitation care

Saigal, S.; Sharma, J.Prakash.; Dhurwe, R.; Kumar, S.; Gurjar, M., 2015:
Targeted temperature management: Current evidence and practices in critical care

Clinkard, D.; Cameron, A.; Howes, D.; Ball, I., 2015:
Targeted temperature management: It is not yet time to change your target temperature

Dries, D.J., 2015:
Targeted temperature management: part 1

Xitong, D.; Xiaorong, Z., 2016:
Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases

Eastwood, G.M.; Schneider, A.G.; Suzuki, S.; Peck, L.; Young, H.; Tanaka, A.; Mårtensson, J.; Warrillow, S.; McGuinness, S.; Parke, R.; Gilder, E.; Mccarthy, L.; Galt, P.; Taori, G.; Eliott, S.; Lamac, T.; Bailey, M.; Harley, N.; Barge, D.; Hodgson, C.L.; Morganti-Kossmann, M.Cristina.; Pébay, A.; Conquest, A.; Archer, J.S.; Bernard, S.; Stub, D.; Hart, G.K.; Bellomo, R., 2017:
Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial)

Grainge, C.L.; Maltby, S.; Gibson, P.G.; Wark, P.A.B.; McDonald, V.M., 2016:
Targeted therapeutics for severe refractory asthma: monoclonal antibodies

Kakavand, H.; Wilmott, J.S.; Long, G.V.; Scolyer, R.A., 2016:
Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists

Cortinovis, D.; Abbate, M.; Bidoli, P.; Capici, S.; Canova, S., 2016:
Targeted therapies and immunotherapy in non-small-cell lung cancer

Jain, N.; O'Brien, S., 2017:
Targeted therapies for CLL: Practical issues with the changing treatment paradigm

Yamamoto-Ibusuki, M.; Arnedos, M.; André, F., 2015:
Targeted therapies for ER+/HER2- metastatic breast cancer

Sathyanarayanan, V.; Hagemeister, F., 2016:
Targeted therapies for Hodgkin lymphoma: results of recent trials

Jiang, Y.; Ludwig, J.; Janku, F., 2015:
Targeted therapies for advanced Ewing sarcoma family of tumors

Pasini, F.; Fraccon, A.Paola.; Modena, Y.; Bencivenga, M.; Giacopuzzi, S.; L.R.ssa, F.; Gusella, M.; de Manzoni, G., 2016:
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new?

Kanellakis, N.I.; Jacinto, T.; Psallidas, I., 2016:
Targeted therapies for lung cancer: how did the game begin?

Lerner, S.P., 2015:
Targeted therapies for metastatic bladder cancer

Kito, Y.; Yamazaki, K., 2015:
Targeted therapies for metastatic colorectal cancer

Grapsa, D.; Saif, M.Wasif.; Syrigos, K., 2015:
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?

Zhou, F.; Zhou, C-Cun., 2016:
Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough

Tan, X.; Liu, Y.; Hou, J.; Cao, G., 2015:
Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus

Arcaro, A., 2016:
Targeted therapies for small cell lung cancer: Where do we stand?

Minguet, J.; Smith, K.H.; Bramlage, P., 2016:
Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives

Minguet, J.; Smith, K.H.; Bramlage, C.P.; Bramlage, P., 2015:
Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives

Woyach, J.A.; Johnson, A.J., 2015:
Targeted therapies in CLL: mechanisms of resistance and strategies for management

Carneiro, R.M.; Carneiro, B.A.; Agulnik, M.; Kopp, P.A.; Giles, F.J., 2015:
Targeted therapies in advanced differentiated thyroid cancer

Yazici, O.; Sendur, M.Ali.Nahit.; Ozdemir, N.; Aksoy, S., 2017:
Targeted therapies in gastric cancer and future perspectives

Tomasello, G.; Ghidini, M.; Liguigli, W.; Ratti, M.; Toppo, L.; Passalacqua, R., 2017 :
Targeted therapies in gastric cancer treatment: where we are and where we are going

Squillante, C.M.; Vaughn, D.J., 2016:
Targeted therapies in germ cell tumors

Moschos, S.J.; Pinnamaneni, R., 2015:
Targeted therapies in melanoma

Leduc, C.; Besse, B., 2015:
Targeted therapies in non-small cell lung cancer in 2014

Abdulrahman Jnr, G.O., 2015:
Targeted therapies in the management of breast cancer

Bikas, A.; Vachhani, S.; Jensen, K.; Vasko, V.; Burman, K.D., 2016:
Targeted therapies in thyroid cancer: an extensive review of the literature

Brodlie, M.; Haq, I.J.; Roberts, K.; Elborn, J.Stuart., 2016:
Targeted therapies to improve CFTR function in cystic fibrosis

Myers, M.B., 2016:
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives

Berghmans, T.; Meert, A-Pascale.; Quoix, E., 2016:
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations

Yang, T.; Rycaj, K., 2015:
Targeted therapy against cancer stem cells

Daste, A.; Chakiba, C.; Domblides, C.; Gross-Goupil, M.; Quivy, A.; Ravaud, A.; Soubeyran, P., 2016:
Targeted therapy and elderly people: A review

Heigener, D.F.; Horn, M.; Reck, M., 2016:
Targeted therapy and precision medicine : More than just words in the treatment of lung cancer

Mohindra, N.; Agulnik, M., 2016:
Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas

Couñago, F.; Rodríguez, A.; Calvo, P.; Luna, J.; Monroy, J.L.; Taboada, B.; Díaz, V.; Rodríguez de Dios, N., 2016:
Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

Lee, H.Gyu.; Kim, H.; Kim, E.Jung.; Park, P-Gu.; Dong, S.Myung.; Choi, T.Hyun.; Kim, H.; Chong, C.R.; Liu, J.O.; Chen, J.; Ambinder, R.F.; Hayward, S.Diane.; Park, J.Han.; Lee, J.Myun., 2016:
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation

Kanat, O.; O'Neil, B.; Shahda, S., 2015:
Targeted therapy for advanced gastric cancer: A review of current status and future prospects

Boguniewicz, M.; Leung, D.Y.M., 2015:
Targeted therapy for allergic diseases: at the intersection of cutting-edge science and clinical practice

Gu, G.; Dustin, D.; Fuqua, S.Aw., 2016:
Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment

Arnason, J.E.; Brown, J.R., 2015:
Targeted therapy for chronic lymphocytic leukemia: current status and future directions

Yuan, D-Dan.; Zhu, Z-Xiu.; Zhang, X.; Liu, J., 2016:
Targeted therapy for gastric cancer: Current status and future directions (Review)

Agarwal, R.; Liebe, S.; Turski, M.L.; Vidwans, S.J.; Janku, F.; Garrido-Laguna, I.; Munoz, J.; Schwab, R.; Rodon, J.; Kurzrock, R.; Subbiah, V., 2015:
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies

Agarwal, R.; Liebe, S.; Turski, M.L.; Vidwans, S.J.; Janku, F.; Garrido-Laguna, I.; Munoz, J.; Schwab, R.; Rodon, J.; Kurzrock, R.; Subbiah, V., 2015:
Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome

Agarwal, R.; Liebe, S.; Turski, M.L.; Vidwans, S.J.; Janku, F.; Garrido-Laguna, I.; Munoz, J.; Schwab, R.; Rodon, J.; Kurzrock, R.; Subbiah, V., 2015:
Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome

Agarwal, R.; Liebe, S.; Turski, M.L.; Vidwans, S.J.; Janku, F.; Garrido-Laguna, I.; Munoz, J.; Schwab, R.; Rodon, J.; Kurzrock, R.; Subbiah, V., 2015:
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome

Paleiron, N.; Bylicki, O.; André, M.; Rivière, E.; Grassin, F.; Robinet, G.; Chouaïd, C., 2016:
Targeted therapy for localized non-small-cell lung cancer: a review

Meert, A-Pascale.; Cadranel, J., 2016:
Targeted therapy for lung cancer

Aggarwal, C., 2015:
Targeted therapy for lung cancer: present and future

Komaba, H.; Fukagawa, M., 2016:
Targeted therapy for mineral and bone disorder

Chan, B.A.; Hughes, B.G.M., 2015:
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Terai, K.; Horie, S., 2016:
Targeted therapy for renal cell carcinoma

Porta, C.; Giglione, P.; Paglino, C., 2016:
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line

Ashinuma, H.; Sekine, I., 2015:
Targeted therapy for solid tumors in the elderly

Pokrywczynska, M.; Adamowicz, J.; Czapiewska, M.; Balcerczyk, D.; Jundzill, A.; Nowacki, M.; Petros, P.; Drewa, T., 2016:
Targeted therapy for stress urinary incontinence: a systematic review based on clinical trials

Simonelli, M.; Zucali, P.A.; Suter, M.B.; Lorenzi, E.; Rubino, L.; Fatuzzo, G.; Alloisio, M.; Santoro, A., 2016:
Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports

Hou, L.; Xu, D.; Dai, W., 2016:
Targeted therapy for thyroid cancer

Laurie, S.A., 2016:
Targeted therapy in BRAF-mutated lung adenocarcinoma

Peters, S.; Zimmermann, S., 2015:
Targeted therapy in NSCLC driven by HER2 insertions

Jordan, E.J.; Iyer, G., 2015:
Targeted therapy in advanced bladder cancer: what have we learned?

Tsimberidou, A-Maria., 2016:
Targeted therapy in cancer

Mutch, D.G., 2016:
Targeted therapy in endometrial cancer: Making progress

Zhang, L.; Ma, J.; Han, Y.; Liu, J.; Zhou, W.; Hong, L.; Fan, D., 2016:
Targeted therapy in esophageal cancer

Formica, V.; Roselli, M., 2015:
Targeted therapy in first line treatment of RAS wild type colorectal cancer

Jomrich, G.; Schoppmann, S.F., 2016:
Targeted therapy in gastric cancer

Woo, J.; Cohen, S.A.; Grim, J.E., 2015:
Targeted therapy in gastroesophageal cancers: past, present and future

Seoud, M.; Lundqvist, E.Åvall.; Fujiwara, K., 2016:
Targeted therapy in gynecologic cancers: Ready for prime time?

Zhu, X.; Verma, S., 2015:
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature

Goldinger, S.M.; Murer, C.; Stieger, P.; Dummer, R., 2013:
Targeted therapy in melanoma - the role of BRAF, RAS and KIT mutations

Milano, Gérard.A., 2016:
Targeted therapy in non-small cell lung cancer: a focus on epidermal growth factor receptor mutations

Lim, H.Jun.; Ledger, W., 2017:
Targeted therapy in ovarian cancer

Conforti, S.; Ceniti, S.; Conforti, L.; Turano, S.; Minardi, S.; Palazzo, S., 2015:
Targeted therapy in renal carcinoma: a case of long-term effect with complete control of toxicity

Tan, C.Jek.; Yang, J-Lin.; Crowe, P.; Goldstein, D., 2013:
Targeted therapy in soft tissue sarcoma-a novel direction in therapeutics

Schwab, C.L.; Santin, A.D., 2016:
Targeted therapy in the treatment of uterine serous carcinoma

Lkhoyaali, S.; Benhmida, S.; Ait Elhaj, M.; Layachi, M.; Bensouda, Y.; Errihani, H., 2016:
Targeted therapy in thyroid cancer: Towards a treatment card

Fujino, T.; Yao, A.; Hatano, M.; Inaba, T.; Muraoka, H.; Minatsuki, S.; Imamura, T.; Maki, H.; Kinugawa, K.; Ono, M.; Nagai, R.; Komuro, I., 2015:
Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension

Carneiro, B.A.; Altman, J.K.; Kaplan, J.B.; Ossenkoppele, G.; Swords, R.; Platanias, L.C.; Giles, F.J., 2015:
Targeted therapy of acute myeloid leukemia

Khondee, S.; Rabinsky, E.F.; Owens, S.R.; Joshi, B.P.; Qiu, Z.; Duan, X.; Zhao, L.; Wang, T.D., 2016:
Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles

Jakhetiya, A.; Garg, P.Kumar.; Prakash, G.; Sharma, J.; Pandey, R.; Pandey, D., 2016:
Targeted therapy of gastrointestinal stromal tumours

Kaluzova, M.; Bouras, A.; Machaidze, R.; Hadjipanayis, C.G., 2016:
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles

Ding, L-Yu.; Liu, K-Jun.; Jiang, Z-Long.; Wu, H-Ying.; Wu, S-Xiu., 2016:
Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma

Geller, D.S.; Morris, J.; Revskaya, E.; Kahn, M.; Zhang, W.; Piperdi, S.; Park, A.; Koirala, P.; Guzik, H.; Hall, C.; Hoang, B.; Yang, R.; Roth, M.; Gill, J.; Gorlick, R.; Dadachova, E., 2016:
Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)

Vipperla, K.; O'Keefe, S.J., 2014:
Targeted therapy of short-bowel syndrome with teduglutide: the new kid on the block

Baradaran, B.; Majidi, J.; Farajnia, S.; Barar, J.; Omidi, Y., 2015:
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor

Drilon, A., 2016:
Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?

Kitson, S.L.; Cuccurullo, V.; Ciarmiello, A.; Mansi, L., 2016:
Targeted therapy towards cancer - A perspective

Camidge, D.Ross., 2015:
Targeted therapy vs chemotherapy: which has had more impact on survival in lung cancer? Does targeted therapy make patients live longer? Hard to prove, but impossible to ignore

Socinski, M.A., 2015:
Targeted therapy vs chemotherapy: which has had more impact on survival in lung cancer? The significant impact of chemotherapy in lung cancer

Bogdahn, U.; Hau, P.; Olyushin, V.; Mahapatra, A.K.; Parfenov, V.; Venkataramana, N.K.; Wassmann, H.; Ludwig, S.; Heinrichs, H.; Schlingensiepen, K.H., 2016:
Targeted therapy with AP 12009 in recurrent or refractory glioblastoma patients: Results of a phase Iib study

Brusselle, G.G.; Bracke, K.; Lahousse, L., 2016:
Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts

Banavali, S.; Pasquier, E.; Andre, N., 2015:
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma

Perri, F.; Pezzullo, L.; Chiofalo, M.Grazia.; Lastoria, S.; D.G.nnaro, F.; Scarpati, G.Della.Vittoria.; Caponigro, F., 2015:
Targeted therapy: a new hope for thyroid carcinomas

Chen, D-Hong.; Zhang, X-Shi., 2016:
Targeted therapy: resistance and re-sensitization

Tadayon, A.; Jamshidi, R.; Esmaeili, A., 2016:
Targeted thrombolysis of tissue plasminogen activator and streptokinase with extracellular biosynthesis nanoparticles using optimized Streptococcus equi supernatant

Pettilä, V.; Merz, T.; Wilkman, E.; Perner, A.; Karlsson, S.; Lange, T.; Hästbacka, J.; Hjortrup, P.Buhl.; Kuitunen, A.; Jakob, S.M.; Takala, J., 2018:
Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial

Jin, H.; Kanthasamy, A.; Harischandra, D.S.; Anantharam, V.; Rana, A.; Kanthasamy, A., 2015:
Targeted toxicants to dopaminergic neuronal cell death

Telving, R.; Hasselstrøm, Jørgen.Bo.; Andreasen, M.Findal., 2016:
Targeted toxicological screening for acidic, neutral and basic substances in postmortem and antemortem whole blood using simple protein precipitation and UPLC-HR-TOF-MS

Popov, T.G.; Carolus, A.; Schubring, D.; Popova, P.; Miller, G.A.; Rockstroh, B.S., 2016:
Targeted training modifies oscillatory brain activity in schizophrenia patients

Anonymous, 2013:
Targeted training planned in older people's care

Iwabuchi, S.J.; Raschke, F.; Auer, D.P.; Liddle, P.F.; Lankappa, S.T.; Palaniyappan, L., 2016:
Targeted transcranial theta-burst stimulation alters fronto-insular network and prefrontal GABA

Boas, F.Edward.; Kadivar, F.; Kelly, P.D.; Drebin, J.A.; Vollmer, C.M.; Shlansky-Goldberg, R.D., 2015:
Targeted transgastric drainage of isolated pancreatic duct segments to cure persistent pancreaticocutaneous fistulas from pancreatitis

Kawabe, Y.; Shimomura, T.; Huang, S.; Imanishi, S.; Ito, A.; Kamihira, M., 2017:
Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors

Barrett, T.; Patterson, A.J.; Koo, B.C.; Wadhwa, K.; Warren, A.Y.; Doble, A.; Gnanapragasam, V.J.; Kastner, C.; Gallagher, F.A., 2015:
Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors

Qi, Y.; Yang, Z.; Ding, Q.; Zhao, T.; Huang, Z.; Feng, G., 2016:
Targeted transplantation of iron oxide-labeled, adipose-derived mesenchymal stem cells in promoting meniscus regeneration following a rabbit massive meniscal defect

Gupta, N.; Wu, C.H.; Wu, G.Y., 2016:
Targeted transplantation of mitochondria to hepatocytes

Geukes Foppen, M.H.; Brandsma, D.; Blank, C.U.; van Thienen, J.V.; Haanen, J.B.; Boogerd, W., 2017:
Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma

Smolej, Láš., 2015:
Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab

Hunt, D.; Milne, P.; Fernandes, P.; Bigley, V.; Collin, M., 2016:
Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA

Faber, E., 2016:
Targeted treatment of chronic myeloid leukemia in the elderly patients

Richeldi, L., 2016:
Targeted treatment of idiopathic pulmonary fibrosis: one step at a time

Gong, J.; Tan, G.; Sheng, N.; You, W.; Wang, Z., 2016:
Targeted treatment of liver metastasis from gastric cancer using specific binding peptide

Mulders, P.F.; D.S.ntis, M.; Powles, T.; Fizazi, K., 2015:
Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy

Sedef, A.Murat.; Köse, F.; Doğan, Özlem.; Ergün, T.; Sezer, A.; Mertsoylu, Hüseyin.; Muallaoğlu, S.; Beşen, A.; Özyilkan, Özgur., 2015:
Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases

Sugumar, D.; Keller, J.; Vij, R., 2015:
Targeted treatments for multiple myeloma: specific role of carfilzomib

de la Fouchardière, C., 2016:
Targeted treatments of radio-iodine refractory differentiated thyroid cancer

Martin-Broto, J.; Hindi, N., 2017:
Targeted treatments of sarcomas and connective tumors beside gastrointestinal stromal tumor

Chen, W.; Liu, B.; Chen, J.; Liu, G.; Liu, X., 2016:
Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes

Lei, Y.; Hamada, Y.; Li, J.; Cong, L.; Wang, N.; Li, Y.; Zheng, W.; Jiang, X., 2017:
Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression

Capolla, S.; Garrovo, C.; Zorzet, S.; Lorenzon, A.; Rampazzo, E.; Spretz, R.; Pozzato, G.; Núñez, L.; Tripodo, C.; Macor, P.; Biffi, S., 2016:
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

Chen, W-Tsung.; Kang, S-Tsung.; Lin, J-Liang.; Wang, C-Hsin.; Chen, R-Chou.; Yeh, C-Kuang., 2016:
Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model

Lajkó, E.; Bányai, Péter.; Zámbó, Zófia.; Kursinszki, László.; Szőke, Éva.; Kőhidai, László., 2015:
Targeted tumor therapy by Rubia tinctorum L.: analytical characterization of hydroxyanthraquinones and investigation of their selective cytotoxic, adhesion and migration modulator effects on melanoma cell lines (A2058 and HT168-M1)

Oettle, H.; Seufferlein, T.; Schmid, R.; Luger, T.; Ludwig, S.; Schmaus, S.; Beyer, M.; Fischer, D.; Hafner, M.; Schlingensiepen, K., 2016:
Targeted tumor therapy with the TGF-beta2 antisense compound AP 12009 for the treatment of advanced solid tumors

Lai, B-Ru.; Wu, Y-Tung.; Kuo, Y-Chia.; Hsu, H-Chih.; Chen, J-Shi.; Chen, T-Ching.; Wu, R-Chin.; Chiu, C-Tang.; Yeh, C-Nan.; Yeh, T-Sen., 2016:
Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question

Kristensen, T.; Broesby-Olsen, S.; Vestergaard, H.; Bindslev-Jensen, C.; Møller, M.Boe., 2015:
Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosis

van Rooij, T.; Daeichin, V.; Skachkov, I.; de Jong, N.; Kooiman, K., 2016:
Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy

Majid, I.; Imran, S., 2016:
Targeted ultraviolet B phototherapy in vitiligo: A comparison between once-weekly and twice-weekly treatment regimens

Alshiyab, D.; Edwards, C.; Chin, M.F.; Anstey, A.V., 2015:
Targeted ultraviolet B phototherapy: definition, clinical indications and limitations

Trinh, T.; Shiner, C.T.; Thompson-Butel, A.G.; McNulty, P.A., 2016:
Targeted upper-limb Wii-based Movement Therapy also improves lower-limb muscle activation and functional movement in chronic stroke

Jo, B.; Findling, R.L.; Wang, C-Pin.; Hastie, T.J.; Youngstrom, E.A.; Arnold, L.Eugene.; Fristad, M.A.; Horwitz, S.McCue., 2016:
Targeted use of growth mixture modeling: a learning perspective

Kimura, M.; Harazaki, M.; Fukuoka, T.; Asakura, I.; Sakai, H.; Kamimaki, T.; Ohkawara, I.; Akiyama, N.; Tsurui, S.; Iwashima, S.; Shimomura, M.; Morishita, H.; Meguro, T.; Seto, S., 2016:
Targeted use of prednisolone with second IVIG for refractory Kawasaki disease

Wentink, M.Q.; Hackeng, T.M.; Tabruyn, S.P.; Puijk, W.C.; Schwamborn, K.; Altschuh, D.; Meloen, R.H.; Schuurman, T.; Griffioen, A.W.; Timmerman, P., 2016:
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

Thorrington, D.; Jit, M.; Eames, K., 2016:
Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza?

Campbell, H.; Saliba, V.; Borrow, R.; Ramsay, M.; Ladhani, S.N., 2015:
Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015

Zarogoulidis, P.; Darwiche, K.; Kalamaras, G.; Huang, H.; Hohenforst-Schmidt, W.; Zarogoulidis, K., 2013:
Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancer

Lytle, B.L.; Li, S.; Lofthus, D.M.; Thomas, L.; Poteat, J.L.; Bhatt, D.L.; Cannon, C.P.; Fonarow, G.C.; Peterson, E.D.; Wang, T.Y.; Alexander, K.P., 2015:
Targeted versus standard feedback: results from a randomized quality improvement trial

Ilicak, E.; Cetin, S.; Bulut, E.; Oguz, K.Karli.; Saritas, E.Ulku.; Unal, G.; Çukur, T., 2016:
Targeted vessel reconstruction in non-contrast-enhanced steady-state free precession angiography

Schouten, R.; Brennan, D.V., 2016:
Targeted violence against law enforcement officers

Visser, M.; Burger, J.T.; Maree, H.J., 2017:
Targeted virus detection in next-generation sequencing data using an automated e-probe based approach

Saha, M.; Das, M.; Nasani, R.; Choudhuri, I.; Yousufuddin, M.; Nayek, H.Pada.; Shaikh, M.M.; Pathak, B.; Mukhopadhyay, S., 2016:
Targeted water soluble copper-tetrazolate complexes: interactions with biomolecules and catecholase like activities

Melville, G., 2016:
Targeted α therapy for cancer: where we are today and where we are heading

Oyen, W.J.G.; de Bono, J.S., 2016:
Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?

Juillerat-Jeanneret, L.; Flohr, A.; Schneider, M.; Walter, I.; Wyss, J-Christophe.; Kumar, R.; Golshayan, D.; Aebi, J.D., 2016 :
Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal Diseases

Srikanth, J.; Agalyadevi, R.; Babu, P., 2016:
Targeted, Site-specific quantitation of N- and O-glycopeptides using 18O-labeling and product ion based mass spectrometry

McPherson, J.G.; Miller, R.R.; Perlmutter, S.I., 2016:
Targeted, activity-dependent spinal stimulation produces long-lasting motor recovery in chronic cervical spinal cord injury

Cai, Y.; Laustsen, A.; Zhou, Y.; Sun, C.; Anderson, M.Valdemar.; Li, S.; Uldbjerg, N.; Luo, Y.; Jakobsen, M.R.; Mikkelsen, J.Giehm., 2016:
Targeted, homology-driven gene insertion in stem cells by ZFN-loaded 'all-in-one' lentiviral vectors

Shivakumar, V.; Narayanaswamy, J.C.; Agarwal, S.Mahavir.; Bose, A.; Subramaniam, A.; Venkatasubramanian, G., 2015:
Targeted, intermittent booster tDCS: a novel add-on application for maintenance treatment in a schizophrenia patient with refractory auditory verbal hallucinations

Benoit, D.Sw.; Koo, H., 2016:
Targeted, triggered drug delivery to tumor and biofilm microenvironments

Xiao, L.; Schultz, Z.D., 2016:
Targeted-TERS detection of integrin receptors on human cancer cells

Kitamoto, T.; Kitamoto, A.; Ogawa, Y.; Honda, Y.; Imajo, K.; Saito, S.; Yoneda, M.; Nakamura, T.; Nakajima, A.; Hotta, K., 2016:
Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease

Horn, L., 2016:
Targeted/emerging therapies for metastatic non-small cell lung cancer

Steiling, K.; Christenson, S.A., 2015 :
Targeting 'types: Precision Medicine in Pulmonary Disease

Bai, A.; Szulc, Z.M.; Bielawski, J.; Pierce, J.S.; Rembiesa, B.; Terzieva, S.; Mao, C.; Xu, R.; Wu, B.; Clarke, C.J.; Newcomb, B.; Liu, X.; Norris, J.; Hannun, Y.A.; Bielawska, A., 2015:
Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs

Ehses, J.A.; Donath, M.Y., 2015:
Targeting 12-lipoxygenase as a novel strategy to combat the effects of inflammation on beta cells in diabetes

Kawamoto, Y.; Sasaki, A.; Chandran, A.; Hashiya, K.; Ide, S.; Bando, T.; Maeshima, K.; Sugiyama, H., 2016:
Targeting 24 bp within Telomere Repeat Sequences with Tandem Tetramer Pyrrole-Imidazole Polyamide Probes

Davies, M-Ann.; Pinto, J., 2016:
Targeting 90-90-90--don't leave children and adolescents behind

Ryan, M.B.; Der, C.J.; Wang-Gillam, A.; Cox, A.D., 2016:
Targeting iRAS -mutant cancers: is ERK the key?

Liu, T.; Li, Z.; Zhang, Q.; De Amorim Bernstein, K.; Lozano-Calderon, S.; Choy, E.; Hornicek, F.J.; Duan, Z., 2016:
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance

Fanelli, Mù.; Hattinger, C.Maria.; Vella, S.; Tavanti, E.; Michelacci, F.; Gudeman, B.; Barnett, D.; Picci, P.; Serra, M., 2016:
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

Yang, Y.; Qiu, J-Ge.; Li, Y.; Di, J-Ming.; Zhang, W-Ji.; Jiang, Q-Wei.; Zheng, D-Wei.; Chen, Y.; Wei, M-Ning.; Huang, J-Rong.; Wang, K.; Shi, Z., 2016:
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing

Sourbier, C.; Ricketts, C.J.; Matsumoto, S.; Crooks, D.R.; Liao, P-Jyun.; Mannes, P.Z.; Yang, Y.; Wei, M-Hui.; Srivastava, G.; Ghosh, S.; Chen, V.; Vocke, C.D.; Merino, M.; Srinivasan, R.; Krishna, M.C.; Mitchell, J.B.; Pendergast, A.Marie.; Rouault, T.A.; Neckers, L.; Linehan, W.Marston., 2015:
Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer

Shah, S.; Carriveau, W.J.; Li, J.; Campbell, S.L.; Kopinski, P.K.; Lim, H-Woong.; Daurio, N.; Trefely, S.; Won, K-Jae.; Wallace, D.C.; Koumenis, C.; Mancuso, A.; Wellen, K.E., 2016:
Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism

Rossello, A.; Nuti, E.; Ferrini, S.; Fabbi, M., 2016:
Targeting ADAM17 Sheddase Activity in Cancer

Mishra, H.K.; Johnson, T.J.; Seelig, D.M.; Walcheck, B., 2016:
Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis

Zakaria, M.Naguib.; El-Bassossy, H.M.; Barakat, W., 2015:
Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats

Yu, Y.; Savage, R.E.; Eathiraj, S.; Meade, J.; Wick, M.J.; Hall, T.; Abbadessa, G.; Schwartz, B., 2016:
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092

Kudo-Saito, C.; Fuwa, T.; Kawakami, Y., 2017:
Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity

Yue, L.; Huang, Z-Ming.; Fong, S.; Leong, S.; Jakowatz, J.G.; Charruyer-Reinwald, A.; Wei, M.; Ghadially, R., 2015:
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma

Liu, X.; Wang, L.; Cui, W.; Yuan, X.; Lin, L.; Cao, Q.; Wang, N.; Li, Y.; Guo, W.; Zhang, X.; Wu, C.; Yang, J., 2016:
Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells

Versteeg, R.; George, R.E., 2016:
Targeting ALK: The Ten Lives of a Tumor

Chaudhuri, A.; Ghanim, H.; Dandona, P., 2016:
Targeting AMP Kinase in Myeloid Cells to Reduce Atherosclerosis

Wang, Z.; Liu, P.; Chen, Q.; Deng, S.; Liu, X.; Situ, H.; Zhong, S.; Hann, S.; Lin, Y., 2017:
Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

Li, W.; Saud, S.M.; Young, M.R.; Chen, G.; Hua, B., 2016:
Targeting AMPK for cancer prevention and treatment

Asiedu, M.N.; Dussor, G.; Price, T.J., 2016:
Targeting AMPK for the Alleviation of Pathological Pain

Yung, M.M.H.; Ngan, H.Y.S.; Chan, D.W., 2016:
Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges

Ou, T.; Hou, X.; Guan, S.; Dai, J.; Han, W.; Li, R.; Wang, W.; Qu, X.; Zhang, M., 2015:
Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay

Guigas, B.; Viollet, B., 2016:
Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators

Gaudet, D.; Brisson, D.; Tremblay, K.; Alexander, V.J.; Singleton, W.; Hughes, S.G.; Geary, R.S.; Baker, B.F.; Graham, M.J.; Crooke, R.M.; Witztum, J.L., 2014:
Targeting APOC3 in the familial chylomicronemia syndrome

Wang, Q.; Hardie, R-Anne.; Hoy, A.J.; van Geldermalsen, M.; Gao, D.; Fazli, L.; Sadowski, M.C.; Balaban, S.; Schreuder, M.; Nagarajah, R.; Wong, J.J-L.; Metierre, C.; Pinello, N.; Otte, N.J.; Lehman, M.L.; Gleave, M.; Nelson, C.C.; Bailey, C.G.; Ritchie, W.; Rasko, J.E.J.; Holst, J., 2015:
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development

Lu, X-Hong.; Mattis, V.B.; Wang, N.; Al-Ramahi, I.; van den Berg, N.; Fratantoni, S.A.; Waldvogel, H.; Greiner, E.; Osmand, A.; Elzein, K.; Xiao, J.; Dijkstra, S.; de Pril, R.; Vinters, H.V.; Faull, R.; Signer, E.; Kwak, S.; Marugan, J.J.; Botas, J.; Fischer, D.F.; Svendsen, C.N.; Munoz-Sanjuan, I.; Yang, X.William., 2015:
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease

Knittel, G.; Liedgens, P.; Reinhardt, H.C., 2015:
Targeting ATM-deficient CLL through interference with DNA repair pathways

Cheung, N.; Fung, T.Kan.; Zeisig, B.B.; Holmes, K.; Rane, J.K.; Mowen, K.A.; Finn, M.G.; Lenhard, B.; Chan, L.Chong.; So, C.Wai.Eric., 2016:
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia

Rizzo, A.N.; Aman, J.; van Nieuw Amerongen, G.P.; Dudek, S.M., 2015:
Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome

Huang, Y.; Zhao, B.; Chetty, I.J.; Brown, S.; Gordon, J.; Wen, N., 2015:
Targeting Accuracy of Image-Guided Radiosurgery for Intracranial Lesions: A Comparison Across Multiple Linear Accelerator Platforms

Busse, H.; Riedel, T.; Garnov, N.; Thörmer, G.; Kahn, T.; Moche, M., 2016:
Targeting Accuracy, Procedure Times and User Experience of 240 Experimental MRI Biopsies Guided by a Clinical Add-On Navigation System

Kimbrough, C.W.; Khanal, A.; Zeiderman, M.; Khanal, B.R.; Burton, N.C.; McMasters, K.M.; Vickers, S.M.; Grizzle, W.E.; McNally, L.R., 2016:
Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo

Jang, J-Young.; Kim, Y-Goo.; Nam, S.Jeong.; Keam, B.; Kim, T.Min.; Jeon, Y.Kyung.; Kim, C.Woo., 2017:
Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer

Farbood, Y.; Sarkaki, A.; Khalaj, L.; Khodagholi, F.; Badavi, M.; Ashabi, G., 2016:
Targeting Adenosine Monophosphate-Activated Protein Kinase by Metformin Adjusts Post-Ischemic Hyperemia and Extracellular Neuronal Discharge in Transient Global Cerebral Ischemia

Nenna, A.; Nappi, F.; Chello, M.; Spadaccio, C., 2016:
Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative

Srour, A.Y.; Fakhoury, A.M.; Brown, R.L., 2018:
Targeting Aflatoxin Biosynthetic Genes

Seymour, T.; Nowak, A.; Kakulas, F., 2015:
Targeting Aggressive Cancer Stem Cells in Glioblastoma

Crompton, J.G.; Sukumar, M.; Restifo, N.P., 2016:
Targeting Akt in cell transfer immunotherapy for cancer

Li, X.; Shao, H.; Taylor, I.R.; Gestwicki, J.E., 2017:
Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70)

Tkaczyk, C.; Hamilton, M.M.; Sadowska, A.; Shi, Y.; Chang, C.S.; Chowdhury, P.; Buonapane, R.; Xiao, X.; Warrener, P.; Mediavilla, J.; Kreiswirth, B.; Suzich, J.; Stover, C.K.; Sellman, B.R., 2017:
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease

Liu, H.; Xu, Y.; Xiang, J.; Long, L.; Green, S.; Yang, Z.; Zimdahl, B.; Lu, J.; Cheng, N.; Horan, L.H.; Liu, B.; Yan, S.; Wang, P.; Diaz, J.; Jin, L.; Nakano, Y.; Morales, J.F.; Zhang, P.; Liu, L-Xing.; Staley, B.K.; Priceman, S.J.; Brown, C.E.; Forman, S.J.; Chan, V.W.; Liu, C., 2016:
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver Cancer

Tong, M.; Dominguez, C.; Didsbury, J.; de la Monte, S.M., 2016:
Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies

van Greunen, D.G.; Cordier, W.; Nell, M.; van der Westhuyzen, C.; Steenkamp, V.; Panayides, J-Lee.; Riley, D.L., 2016:
Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil

Thackeray, J.T.; Bankstahl, J.P.; Wang, Y.; Wollert, K.C.; Bengel, F.M., 2017:
Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction

Shi, L.; Lin, H.; Li, G.; Jin, R-An.; Xu, J.; Sun, Y.; Ma, W-Lung.; Yeh, S.; Cai, X.; Chang, C., 2017:
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression

Sharp, A.; Welti, J.; Blagg, J.; de Bono, J.S., 2018:
Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer

Yang, Y.Chi.; Banuelos, C.Adriana.; Mawji, N.R.; Wang, J.; Kato, M.; Haile, S.; McEwan, I.J.; Plymate, S.; Sadar, M.D., 2018:
Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer

Zhao, Y.; Adjei, A.A., 2016:
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor

Petrovic, N., 2017:
Targeting Angiogenesis in Cancer Treatments: Where do we Stand?

Kircher, S.Mehta.; Nimeiri, H.S.; Benson, A.B., 2016:
Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors

Khan, K.; Cunningham, D.; Chau, I., 2015:
Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions

de Moraes, M.Cristina.; Cardoso, C.Lucia.; Seidl, Cáudia.; Moaddel, R.; Cass, Q.Bezerra., 2016:
Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays

Sun, L., 2016:
Targeting Anti-Cancer Agents and Cancer Treatments

Bonami, R.H.; Thomas, J.W., 2016:
Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice

Chellat, M.F.; Raguž, L.; Riedl, R., 2018:
Targeting Antibiotic Resistance

Kato, Y.; Zaid, A.; Davey, G.M.; Mueller, S.N.; Nutt, S.L.; Zotos, D.; Tarlinton, D.M.; Shortman, K.; Lahoud, M.H.; Heath, W.R.; Caminschi, I., 2015:
Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall

Wadwa, M.; Klopfleisch, R.; Buer, J.; Westendorf, A.M., 2016:
Targeting Antigens to Dec-205 on Dendritic Cells Induces Immune Protection in Experimental Colitis in Mice

Arambula, J.F.; McCall, R.; Sidoran, K.J.; Magda, D.; Mitchell, N.A.; Bielawski, C.W.; Lynch, V.M.; Sessler, J.L.; Arumugam, K., 2016:
Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells

Ragni, M.V., 2015:
Targeting Antithrombin to Treat Hemophilia

Yang, Y.; Hu, Y.; Wang, H., 2016:
Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives

Guo, R.; Rogers, O.; Nair, S., 2016:
Targeting Apelinergic System in Cardiometabolic Disease

Khetarpal, S.A.; Qamar, A.; Millar, J.S.; Rader, D.J., 2017:
Targeting ApoC-III to Reduce Coronary Disease Risk

Taskapilioglu, M.Ozgur.; Billur, D.; Kizil, S.; Taskapilioglu, O.; Ocakoglu, G.; Aydin, S.; Bekar, A.; Unlu, A., 2016:
Targeting Apoptosis Through Foxp1, and N-cadherin with Glatiramer Acetate in Chick Embryos During Neural Tube Development

Khan, M.; Maryam, A.; Qazi, J.Iqbal.; Ma, T., 2016:
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells

Koonce, N.A.; Levy, J.; Hardee, M.E.; Jamshidi-Parsian, A.; Vang, K.B.; Sharma, S.; Raleigh, J.A.; Dings, R.P.M.; Griffin, R.J., 2016:
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia

Li, S.; Hao, L.; Wang, L.; Lu, Y.; Li, Q.; Zhu, Z.; Shao, J-Zhong.; Chen, W., 2016:
Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology

Pogue, S.L.; Taura, T.; Bi, M.; Yun, Y.; Sho, A.; Mikesell, G.; Behrens, C.; Sokolovsky, M.; Hallak, H.; Rosenstock, M.; Sanchez, E.; Chen, H.; Berenson, J.; Doyle, A.; Nock, S.; Wilson, D.S., 2016:
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

Zhu, Q.; Yu, X.; Zhou, Z-Wei.; Zhou, C.; Chen, X-Wu.; Zhou, S-Feng., 2016:
Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells

Thorburn, A.; Morgan, M.J., 2016:
Targeting Autophagy in BRAF-Mutant Tumors

Blaho, J.A., 2016:
Targeting Autophagy in Dendritic Cells as a Mechanism to Limit Immunopathogenesis in Herpetic Stromal Keratitis

Noonan, J.; Zarrer, J.; Murphy, B.M., 2017:
Targeting Autophagy in Glioblastoma

Franks, S.Elizabeth.; Getahun, A.; Hogarth, P.Mark.; Cambier, J.C., 2016:
Targeting B cells in treatment of autoimmunity

Tai, Y-Tzu.; Anderson, K.C., 2016:
Targeting B-cell maturation antigen in multiple myeloma

Mensali, N.; Ying, F.; Sheng, V.Oei.Yi.; Yang, W.; Walseng, E.; Kumari, S.; Fallang, L-Egil.; Kolstad, A.; Uckert, W.; Malmberg, K.Johan.; Wälchli, Sébastien.; Olweus, J., 2016:
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA

Solimando, A.Giovanni.; Ribatti, D.; Vacca, A.; Einsele, H., 2016:
Targeting B-cell non Hodgkin lymphoma: New and old tricks

Sharman, J.; D.P.olo, J., 2016:
Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib

Poon, W.; Zhang, X.; Bekah, D.; Teodoro, J.G.; Nadeau, J.L., 2016 :
Targeting B16 tumors in vivo with peptide-conjugated gold nanoparticles

Houssiau, Fédéric.A.; Doria, A., 2016:
Targeting BAFF/BLyS in lupus: is the glass half-full or half-empty?

Aveic, S.; Viola, G.; Accordi, B.; Micalizzi, C.; Santoro, N.; Masetti, R.; Locatelli, F.; Basso, G.; Pigazzi, M., 2015:
Targeting BAG-1: a novel strategy to increase drug efficacy in acute myeloid leukemia

Leonard, J.T.; Rowley, J.S.J.; Eide, C.A.; Traer, E.; Hayes-Lattin, B.; Loriaux, M.; Spurgeon, S.E.; Druker, B.J.; Tyner, J.W.; Chang, B.H., 2017:
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia

Roberts, A.W.; Huang, D., 2016:
Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies

Roberts, A.W.; Davids, M.S.; Pagel, J.M.; Kahl, B.S.; Puvvada, S.D.; Gerecitano, J.F.; Kipps, T.J.; Anderson, M.Ann.; Brown, J.R.; Gressick, L.; Wong, S.; Dunbar, M.; Zhu, M.; Desai, M.B.; Cerri, E.; Heitner Enschede, S.; Humerickhouse, R.A.; Wierda, W.G.; Seymour, J.F., 2016:
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

Vogler, M., 2014:
Targeting BCL2-Proteins for the Treatment of Solid Tumours

Walker, S.R.; Frank, D.A., 2015:
Targeting BCL6 and STAT3 in triple negative breast cancer: the one-two punch?

Hantschel, O., 2015:
Targeting BCR-ABL and JAK2 in Ph+ ALL

Jung, M.; Gelato, K.A.; Fernández-Montalván, A.; Siegel, S.; Haendler, B., 2015:
Targeting BET bromodomains for cancer treatment

Fordjour, P.Asare.; Wang, L.; Gao, H.; Li, L.; Wang, Y.; Nyagblordzro, M.; Agyemang, K.; Fan, G., 2018:
Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy

Roy, A., 2016:
Targeting BPOZ-2 in Lewy body disease

Abdel-Rahman, O., 2016:
Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside

Uguen, A.; Marcorelles, P.; D.B.aekeleer, M., 2016:
Targeting BRAF mutants in clear-cell sarcomas of soft tissue: beyond sarcoma or melanoma classification

Zimmer, J.; Tacconi, E.M.C.; Folio, C.; Badie, S.; Porru, M.; Klare, K.; Tumiati, M.; Markkanen, E.; Halder, S.; Ryan, A.; Jackson, S.P.; Ramadan, K.; Kuznetsov, S.G.; Biroccio, A.; Sale, J.E.; Tarsounas, M., 2016:
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds

Huang, F.; Goyal, N.; Sullivan, K.; Hanamshet, K.; Patel, M.; Mazina, O.M.; Wang, C.X.; An, W.Frank.; Spoonamore, J.; Metkar, S.; Emmitte, K.A.; Cocklin, S.; Skorski, T.; Mazin, A.V., 2017:
Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors

Kwon, S-Jung.; Lee, S-Ki.; Na, J.; Lee, S-Ai.; Lee, H-Sae.; Park, J-Hye.; Chung, J-Key.; Youn, H.; Kwon, J., 2015:
Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo

Jiang, J.; Gui, F.; He, Z.; Li, L.; Li, Y.; Li, S.; Wu, X.; Deng, Z.; Sun, X.; Huang, X.; Huang, W.; Han, S.; Zhang, T.; Wang, Z.; Jiao, B.; Song, S.; Wang, H.; Chen, L.; Zhou, D.; Liu, Q.; Ren, R.; Zhang, J.; Deng, X., 2016:
Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors

Bottoni, A.; Rizzotto, L.; Lai, T-Huei.; Liu, C.; Smith, L.L.; Mantel, R.; Reiff, S.; El-Gamal, D.; Larkin, K.; Johnson, A.J.; Lapalombella, R.; Lehman, A.; Plunkett, W.; Byrd, J.C.; Blachly, J.S.; Woyach, J.A.; Sampath, D., 2016:
Targeting BTK through microRNA in chronic lymphocytic leukemia

Kolar, S.L.; Liu, G.Y., 2016:
Targeting Bacterial Abscess Formation

Mesleh, M.F.; Rajaratnam, P.; Conrad, M.; Chandrasekaran, V.; Liu, C.M.; Pandya, B.A.; Hwang, Y.Seok.; Rye, P.T.; Muldoon, C.; Becker, B.; Zuegg, J.; Meutermans, W.; Moy, T.I., 2016:
Targeting Bacterial Cell Wall Peptidoglycan Synthesis by Inhibition of Glycosyltransferase Activity

Smith, R.P.; Paxman, J.J.; Scanlon, M.J.; Heras, Bña., 2017:
Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents

Holden, J.K.; Lewis, M.C.; Cinelli, M.A.; Abdullatif, Z.; Pensa, A.V.; Silverman, R.B.; Poulos, T.L., 2016:
Targeting Bacterial Nitric Oxide Synthase with Aminoquinoline-Based Inhibitors

Guler, R.; Roy, S.; Suzuki, H.; Brombacher, F., 2016:
Targeting Batf2 for infectious diseases and cancer

Peng, B.; Ganapathy, S.; Shen, L.; Huang, J.; Yi, B.; Zhou, X.; Dai, W.; Chen, C., 2016:
Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras

Chen, G.; Deng, X., 2015:
Targeting Bcl2 in cancer

Lallous, N.; Leblanc, E.; Munuganti, R.S.N.; Hassona, M.D.H.; Nakouzi, N.Al.; Awrey, S.; Morin, H.; Roshan-Moniri, M.; Singh, K.; Lawn, S.; Yamazaki, T.; Adomat, H.H.; Andre, C.; Daugaard, M.; Young, R.N.; Guns, E.S.Tomlinson.; Rennie, P.S.; Cherkasov, A., 2016:
Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation

Dalecki, A.G.; Crawford, C.L.; Wolschendorf, F., 2017:
Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Dhaun, N.; Webb, D.J., 2016:
Targeting Blood Vessel Stiffness to Protect Kidney Function

Shaaban, S.; Alsulami, M.; Arbab, S.A.; Ara, R.; Shankar, A.; Iskander, A.; Angara, K.; Jain, M.; Bagher-Ebadian, H.; Achyut, B.R.; Arbab, A.S., 2016:
Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma

El-Amm, J.; Aragon-Ching, J.B., 2016:
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer

Anonymous, 2016:
Targeting Both Tumor and Stroma Cells to Treat Melanoma: NIPAWILMA

Jin, X.; Mu, P., 2015:
Targeting Breast Cancer Metastasis

Xia, B.; Qu, F.; Yuan, T.; Zhang, Y., 2016:
Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of B-cell malignancies

Wang, Y.; Zhang, L.L.; Champlin, R.E.; Wang, M.L., 2015:
Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies

Wang, J.Dao.; Chen, X.Ying.; Ji, K.Wei.; Tao, F., 2016:
Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth

Thiele, J.R.; Zeller, J.; Bannasch, H.; Stark, G.B.; Peter, K.; Eisenhardt, S.U., 2016:
Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes

Yan, H.; Kamiya, T.; Suabjakyong, P.; Tsuji, N.M., 2015:
Targeting C-Type Lectin Receptors for Cancer Immunity

Rué, L.; Bañez-Coronel, Mónica.; Creus-Muncunill, J.; Giralt, A.; Alcalá-Vida, R.; Mentxaka, G.; Kagerbauer, B.; Zomeño-Abellán, M.Teresa.; Aranda, Z.; Venturi, V.; Pérez-Navarro, E.; Estivill, X.; Martí, Eàlia., 2016:
Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels

Zhu, C.; Xu, B.; Sun, X.; Zhu, Q.; Sui, Y., 2016:
Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease

Al-Hussaini, M.; Rettig, M.P.; Ritchey, J.K.; Karpova, D.; Uy, G.L.; Eissenberg, L.G.; Gao, F.; Eades, W.C.; Bonvini, E.; Chichili, G.R.; Moore, P.A.; Johnson, S.; Collins, L.; DiPersio, J.F., 2016:
Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform

Yu, C-Chia.; Hu, F-Wei.; Yu, C-Hang.; Chou, M-Yung., 2014:
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells

Qi, X.; Yu, D.; Jia, B.; Jin, C.; Liu, X.; Zhao, X.; Zhang, G., 2015:
Targeting CD133(+) laryngeal carcinoma cells with chemotherapeutic drugs and siRNA against ABCG2 mediated by thermo/pH-sensitive mesoporous silica nanoparticles

Zhao, L.; Yang, Y.; Zhou, P.; Ma, H.; Zhao, X.; He, X.; Wang, T.; Zhang, J.; Liu, Y.; Zhang, T., 2016:
Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody

Lum, L.G.; Thakur, A.; Kondadasula, S.Vidya.; Al-Kadhimi, Z.; Deol, A.; Tomaszewski, E.N.; Yano, H.; Schalk, D.L.; Ayash, L.; Zonder, J.A.; Uberti, J.P.; Abidi, M.H.; Ratanatharathorn, V., 2016:
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity

Yang, Y.; Hernandez, R.; Rao, J.; Yin, L.; Qu, Y.; Wu, J.; England, C.G.; Graves, S.A.; Lewis, C.M.; Wang, P.; Meyerand, M.E.; Nickles, R.J.; Bian, X-Wu.; Cai, W., 2016:
Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas

Liu, T.; wang, S.; Wang, L.; Wang, J.; Li, Y., 2016:
Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion

Hillen, M.R.; Moret, F.M.; van der Wurff-Jacobs, K.; Radstake, T.; Hack, C.E.; Lafeber, F.; van Roon, J., 2016:
Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis

Chu, Y.; Hochberg, J.; Yahr, A.; Ayello, J.; van de Ven, C.; Barth, M.; Czuczman, M.; Cairo, M.S., 2016:
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice

Elhai, M.; Chiocchia, G.; Marchiol, C.; Lager, F.; Renault, G.; Colonna, M.; Bernhardt, G.; Allanore, Y.; Avouac, Jérôme., 2015:
Targeting CD226/DNAX accessory molecule-1 (DNAM-1) in collagen-induced arthritis mouse models

Alperovich, A.; Younes, A., 2016:
Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma

Leonard, J.P.; Younes, A.; Rosenblatt, J.D.; Gopal, A.; Pinter-Brown, L.C.; Bartlett, N.L.; Burns, L.J.; Forero, A.; Barton, J., 2016:
Targeting CD30 as therapy for Hodgkin's disease. Phase II results with the monoclonal antibody SGN-30

Lourenco, P.D.M.; Rawski, R.; Mohammed, M.F.; Khosa, F.; Nicolaou, S.; McLaughlin, P., 2018:
Dual-Energy CT Iodine Mapping and 40-keV Monoenergetic Applications in the Diagnosis of Acute Bowel Ischemia

Hari, P.; Raj, R.V.; Olteanu, H., 2016:
Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma

Lokhorst, H.M.; Plesner, T.; Laubach, J.P.; Nahi, H.; Gimsing, P.; Hansson, M.; Minnema, M.C.; Lassen, U.; Krejcik, J.; Palumbo, A.; van de Donk, N.W.C.J.; Ahmadi, T.; Khan, I.; Uhlar, C.M.; Wang, J.; Sasser, A.Kate.; Losic, N.; Lisby, S.; Basse, L.; Brun, N.; Richardson, P.G., 2015:
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Celada, L.J.; Drake, W.P., 2015:
Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Molejon, M.Inés.; Tellechea, J.Ignacio.; Moutardier, V.; Gasmi, M.; Ouaissi, M.; Turrini, O.; Delpero, J-Robert.; Dusetti, N.; Iovanna, J., 2015:
Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

Li, C-Rui.; Mueller, E.E.; Bradley, L.M., 2015:
Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes

Arabi, L.; Badiee, A.; Mosaffa, F.; Jaafari, M.Reza., 2015:
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Jeannot, V.; Mazzaferro, S.; Lavaud, J.; Vanwonterghem, L.; Henry, M.; Arboléas, Mélanie.; Vollaire, J.; Josserand, Véronique.; Coll, J-Luc.; Lecommandoux, Sébastien.; Schatz, C.; Hurbin, A., 2016:
Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route

Hristodorov, D.; Mladenov, R.; von Felbert, V.; Huhn, M.; Fischer, R.; Barth, S.; Thepen, T., 2016:
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies

Hay, C.M.; Sult, E.; Huang, Q.; Mulgrew, K.; Fuhrmann, S.R.; McGlinchey, K.A.; Hammond, S.A.; Rothstein, R.; Rios-Doria, J.; Poon, E.; Holoweckyj, N.; Durham, N.M.; Leow, C.Ching.; Diedrich, G.; Damschroder, M.; Herbst, R.; Hollingsworth, R.E.; Sachsenmeier, K.F., 2016:
Targeting CD73 in the tumor microenvironment with MEDI9447

Yap, M.; Brouard, S.; Pecqueur, C.; Degauque, N., 2015:
Targeting CD8 T-Cell Metabolism in Transplantation

Di Meglio, P.; Villanova, F.; Navarini, A.A.; Mylonas, A.; Tosi, I.; Nestle, F.O.; Conrad, C., 2016:
Targeting CD8(+) T cells prevents psoriasis development

Wright, H.J.; Police, A.M.; Razorenova, O.V., 2016:
Targeting CDCP1 dimerization in triple-negative breast cancer

Sherr, C.J.; Beach, D.; Shapiro, G.I., 2016:
Targeting CDK4 and CDK6: From Discovery to Therapy

Hamilton, E.; Infante, J.R., 2016:
Targeting CDK4/6 in patients with cancer

Gutiérrez-Vargas, J.A.; Moreno, H.; Cardona-Gómez, G.P., 2016:
Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity

Tadesse, S.; Yu, M.; Kumarasiri, M.; Le, B.Thuy.; Wang, S., 2016:
Targeting CDK6 in cancer: State of the art and new insights

Rahaman, M.H.; Kumarasiri, M.; Mekonnen, L.B.; Yu, M.; Diab, S.; Albrecht, H.; Milne, R.W.; Wang, S., 2016:
Targeting CDK9: a promising therapeutic opportunity in prostate cancer

Vella, S.; Tavanti, E.; Hattinger, C.Maria.; Fanelli, Mù.; Versteeg, R.; Koster, J.; Picci, P.; Serra, M., 2016:
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells

Wrobel Goldberg, S.; Silberstein, S.David., 2016:
Targeting CGRP: A New Era for Migraine Treatment

Jia, G.; Sowers, J.R., 2016:
Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance

Tullett, K.M.; Leal Rojas, I.M.; Minoda, Y.; Tan, P.S.; Zhang, J-Guo.; Smith, C.; Khanna, R.; Shortman, K.; Caminschi, I.; Lahoud, M.H.; Radford, K.J., 2016:
Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition

Sung, G-Jun.; Choi, H-Kyoung.; Kwak, S.; Song, J-Hye.; Ko, H.; Yoon, H-Geun.; Kang, H-Bum.; Choi, K-Chul., 2016:
Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation

Suarez, C.D.; Deng, X.; Hu, C-Deng., 2014:
Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells

Chen, S-Le.; Cai, S-Rong.; Zhang, X-Hua.; Li, W-Feng.; Zhai, E-Tao.; Peng, J-Jun.; Wu, H.; Chen, C-Qi.; Ma, J-Ping.; Wang, Z.; He, Y-Long., 2016:
Targeting CRMP-4 by lentivirus-mediated RNA interference inhibits SW480 cell proliferation and colorectal cancer growth

Pentland, I.; Parish, J.L., 2016:
Targeting CTCF to Control Virus Gene Expression: A Common Theme amongst Diverse DNA Viruses

Speeckaert, R.; van Geel, N., 2016:
Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo

Huber, A.K.; Irani, D.N., 2016:
Targeting CXCL13 During Neuroinflammation

Brandolini, L.; Cristiano, L.; Fidoamore, A.; D.P.zzol, M.; D.G.acomo, E.; Florio, T.Marilena.; Confalone, G.; Galante, A.; Cinque, B.; Benedetti, E.; Ruffini, P.Adelchi.; Cifone, M.Grazia.; Giordano, A.; Alecci, M.; Allegretti, M.; Cimini, A., 2016:
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling

Dragoj, M.; Milosevic, Z.; Bankovic, J.; Tanic, N.; Pesic, M.; Stankovic, T., 2016:
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma

Mercurio, L.; Ajmone-Cat, M.Antonietta.; Cecchetti, S.; Ricci, A.; Bozzuto, G.; Molinari, A.; Manni, I.; Pollo, B.; Scala, S.; Carpinelli, G.; Minghetti, L., 2016:
Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model

Landry, B.; Gül-Uludağ, H.; Plianwong, S.; Kucharski, C.; Zak, Z.; Parmar, M.B.; Kutsch, O.; Jiang, H.; Brandwein, J.; Uludağ, H., 2016:
Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia

Sisignano, M.; Angioni, C.; Park, C-Kyu.; Meyer Dos Santos, S.; Jordan, H.; Kuzikov, M.; Liu, D.; Zinn, S.; Hohman, S.W.; Schreiber, Y.; Zimmer, Béla.; Schmidt, M.; Lu, R.; Suo, J.; Zhang, D-Dong.; Schäfer, S.M.G.; Hofmann, M.; Yekkirala, A.S.; de Bruin, N.; Parnham, M.J.; Woolf, C.J.; Ji, R-Rong.; Scholich, K.; Geisslinger, G., 2016:
Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

Rabelo, V.W.; Santos, Tísa.F.; Terra, L.; Santana, M.V.; Castro, H.C.; Rodrigues, C.R.; Abreu, P.A., 2016:
Targeting CYP51 for drug design by the contributions of molecular modeling

Raynal, Nël.J-M.; Lee, J.T.; Wang, Y.; Beaudry, A.; Madireddi, P.; Garriga, J.; Malouf, G.G.; Dumont, S.; Dettman, E.J.; Gharibyan, V.; Ahmed, S.; Chung, W.; Childers, W.E.; Abou-Gharbia, M.; Henry, R.A.; Andrews, A.J.; Jelinek, J.; Cui, Y.; Baylin, S.B.; Gill, D.L.; Issa, J-Pierre.J., 2016:
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer

Subramanian, N.; Kanwar, J.R.; Kanwar, R.K.; Krishnakumar, S., 2016 :
Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras

Matsumoto, K.; Hayashi, K.; Murata-Hirai, K.; Iwasaki, M.; Okamura, H.; Minato, N.; Morita, C.T.; Tanaka, Y., 2016:
Targeting Cancer Cells with a Bisphosphonate Prodrug

Tran, Q.; Lee, H.; Park, J.; Kim, S-Hwan.; Park, J., 2016:
Targeting Cancer Metabolism - Revisiting the Warburg Effects

Vernieri, C.; Casola, S.; Foiani, M.; Pietrantonio, F.; de Braud, F.; Longo, V., 2016:
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions

Yun, E-Jin.; Zhou, J.; Lin, C-Jung.; Hernandez, E.; Fazli, L.; Gleave, M.; Hsieh, J-Tsong., 2016:
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Xu, Q.; Le, A.D., 2016:
Targeting Cancer Stem Cells in Oral Cancer

Kuhlmann, J.Dominik.; Hein, L.; Kurth, I.; Wimberger, P.; Dubrovska, A., 2016:
Targeting Cancer Stem Cells: Promises and Challenges

Azmi, A.S.; Mohammad, R.M., 2016:
Targeting Cancer at the Nuclear Pore

Gherardini, L.; Sharma, A.; Capobianco, E.; Cinti, C., 2016:
Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective

Ota, Y.; Itoh, Y.; Kaise, A.; Ohta, K.; Endo, Y.; Masuda, M.; Sowa, Y.; Sakai, T.; Suzuki, T., 2016:
Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen

Vila, T.; Romo, J.A.; Pierce, C.G.; McHardy, S.F.; Saville, S.P.; Lopez-Ribot, Jé.L., 2016:
Targeting Candida albicans filamentation for antifungal drug development

Navarro, G.; Morales, P.; Rodríguez-Cueto, C.; Fernández-Ruiz, J.; Jagerovic, N.; Franco, R., 2016:
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

McCann, K.J.; Mander, A.; Cazaly, A.; Chudley, L.; Stasakova, J.; Thirdborough, S.; King, A.; Lloyd-Evans, P.; Buxton, E.; Edwards, C.; Halford, S.; Bateman, A.; O'Callaghan, A.; Clive, S.; Anthoney, A.; Jodrell, D.I.; Weinschenk, T.; Simon, P.; Sahin, U.; Thomas, G.J.; Stevenson, F.K.; Ottensmeier, C.H., 2016:
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes

Bhootada, Y.; Choudhury, S.; Gully, C.; Gorbatyuk, M., 2015:
Targeting Caspase-12 to Preserve Vision in Mice With Inherited Retinal Degeneration

Ruan, H.; Hao, S.; Young, P.; Zhang, H., 2015:
Targeting Cathepsin B for Cancer Therapies

Wang, L.; Zhang, J.; Wan, L.; Zhou, X.; Wang, Z.; Wei, W., 2015:
Targeting Cdc20 as a novel cancer therapeutic strategy

Chen-Kiang, S.; D.L.berto, M.; Louie, T.; Liang, J.; Jayabalan, D.S.; Ely, S.; Moore, M.A.; Niesvizky, R.; Huang, X., 2016:
Targeting Cdk4/6 in combination therapy of chemoresistant multiple myeloma

Parmar, M.B.; Aliabadi, H.Montazeri.; Mahdipoor, P.; Kucharski, C.; Maranchuk, R.; Hugh, J.C.; Uludağ, H., 2015:
Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines

Garg, J.P.; Vucic, D., 2018:
Targeting Cell Death Pathways for Therapeutic Intervention in Kidney Diseases

Paramelle, D.; Nieves, D.; Brun, B.; Kraut, R.S.; Fernig, D.G., 2016:
Targeting Cell Membrane Lipid Rafts by Stoichiometric Functionalization of Gold Nanoparticles With a Sphingolipid-Binding Domain Peptide

Pandey, M.K.; Prasad, S.; Tyagi, A.Kumar.; Deb, L.; Huang, J.; Karelia, D.N.; Amin, S.G.; Aggarwal, B.B., 2016:
Targeting Cell Survival Proteins for Cancer Cell Death

Ma, S.; Jia, R.; Li, D.; Shen, B., 2016:
Targeting Cellular Metabolism Chemosensitizes the Doxorubicin-Resistant Human Breast Adenocarcinoma Cells

Pires, B.Ricardo.Barreto.; D.A.orim, Ísis.Salviano.Soares.; Souza, L.Duarte.E.; Rodrigues, J.Alves.; Mencalha, A.Luiz., 2016:
Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment

Fereidan-Esfahani, M.; Brück, W.; Weber, M.S., 2016:
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?

Kühn, M.W.M.; Song, E.; Feng, Z.; Sinha, A.; Chen, C-Wei.; Deshpande, A.J.; Cusan, M.; Farnoud, N.; Mupo, A.; Grove, C.; Koche, R.; Bradner, J.E.; de Stanchina, E.; Vassiliou, G.S.; Hoshii, T.; Armstrong, S.A., 2016:
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia

Pasini, A.; Delmonte, A.; Tesei, A.; Calistri, D.; Giordano, E., 2016:
Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results

Panza, F.; Seripa, D.; Solfrizzi, V.; Tortelli, R.; Greco, A.; Pilotto, A.; Logroscino, G., 2016:
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype

Ning, S-Tzu.; Lee, S-Yu.; Wei, M-Feng.; Peng, C-Liang.; Lin, S.Yun-Fan.; Tsai, M-Hsien.; Lee, P-Chi.; Shih, Y-Hsia.; Lin, C-Yen.; Luo, T-Yueh.; Shieh, M-Jium., 2016:
Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles

Mentz, R.J.; Maddox, T.M., 2016:
Targeting Comorbidities in Elderly Patients With Heart Failure: The OPTIMIZE-HFPEF Trial

Yu, Z.X.; Qi, S.; Lasaro, M.A.; Bouchard, K.; Dow, C.; Moore, K.; Wu, Z.; Barama, A.; Xu, J.; Johnson, K.; Marozsan, A.J.; Wang, Y., 2017:
Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function

Pavón, M.Ángel.; López-Calleja, Iés.María.; González, I.; Martín, R.; García, T., 2018:
Targeting Conserved Genes in Alternaria Species

Kocsubé, Sándor.; Varga, János., 2018:
Targeting Conserved Genes in Aspergillus Species

Gil-Serna, Jéssica.; Patiño, Bén.; Jurado, M.; Mirete, S.; Vázquez, C.; González-Jaén, M.Teresa., 2018:
Targeting Conserved Genes in Fusarium Species

Peterson, S.W., 2018:
Targeting Conserved Genes in Penicillium Species

Carson, S., 2016:
Targeting Critical Thinking Skills in a First-Year Undergraduate Research Course

Bulatov, E.; Ciulli, A., 2015:
Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation

Santo, L.; Siu, K.Tat.; Raje, N., 2016 :
Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers

Vlenterie, M.; Hillebrandt-Roeffen, M.H.S.; Schaars, E.W.M.; Flucke, U.E.; Fleuren, E.D.G.; Navis, A.C.; Leenders, W.P.J.; Versleijen-Jonkers, Y.M.H.; van der Graaf, W.T.A., 2018:
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients

Majtan, T.; Pey, A.L.; Ereño-Orbea, J.; Martínez-Cruz, L.Alfonso.; Kraus, J.P., 2017:
Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions

von Mässenhausen, A.; Sanders, C.; Brägelmann, J.; Konantz, M.; Queisser, A.; Vogel, W.; Kristiansen, G.; Duensing, S.; Schröck, A.; Bootz, F.; Brossart, P.; Kirfel, J.; Lengerke, C.; Perner, S., 2017:
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib

Bol, G.M.; Vesuna, F.; Xie, M.; Zeng, J.; Aziz, K.; Gandhi, N.; Levine, A.; Irving, A.; Korz, D.; Tantravedi, S.; Heerma van Voss, M.R.; Gabrielson, K.; Bordt, E.A.; Polster, B.M.; Cope, L.; van der Groep, P.; Kondaskar, A.; Rudek, M.A.; Hosmane, R.S.; van der Wall, E.; van Diest, P.J.; Tran, P.T.; Raman, V., 2016:
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy

Li, L.; Zhu, T.; Gao, Y-Feng.; Zheng, W.; Wang, C-Jing.; Xiao, L.; Huang, M-Sha.; Yin, J-Ye.; Zhou, H-Hao.; Liu, Z-Qian., 2016:
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer

He, L.; Zhang, Y.; Sun, H.; Jiang, F.; Yang, H.; Wu, H.; Zhou, T.; Hu, S.; Kathera, C.Sekhar.; Wang, X.; Chen, H.; Li, H.; Shen, B.; Zhu, Y.; Guo, Z., 2016:
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression

Boyle, K.M.; Barton, J.K., 2016:
Targeting DNA Mismatches with Rhodium Metalloinsertors

Castro, E.; Mateo, J.; Olmos, D.; de Bono, J.S., 2016:
Targeting DNA Repair: The Role of PARP Inhibition in the Treatment of Castration-Resistant Prostate Cancer

Zhang, J.; Dai, Q.; Park, D.; Deng, X., 2016:
Targeting DNA Replication Stress for Cancer Therapy

Yiannakopoulou, E.C., 2016:
Targeting DNA methylation with green tea catechins

Viallard, C.; Chezal, J-Michel.; Mishellany, F.; Ranchon-Cole, I.; Pereira, B.; Herbette, Aélie.; Besse, S.; Boudhraa, Z.; Jacquemot, N.; Cayre, A.; Miot-Noirault, E.; Sun, J-Sheng.; Dutreix, M.; Degoul, Fçoise., 2016:
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy

Starczewska, E.; Beyaert, M.; Michaux, L.; Vekemans, M-Christiane.; Saussoy, P.; Bol, V.; Arana Echarri, A.; Smal, C.; Van Den Neste, E.; Bontemps, Fçoise., 2016:
Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs

Puigvert, J.Carreras.; Sanjiv, K.; Helleday, T., 2016:
Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies

Li, X.; Tian, J.; Bo, Q.; Li, K.; Wang, H.; Liu, T.; Li, J., 2016:
Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63

Anonymous, 2016:
Targeting DOT1L May Reverse Leukemogenic Effects of Mutant DNMT3A

Chen, C-Wei.; Armstrong, S.A., 2015:
Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond

Freitas-Silva, R.; Brelaz-de-Castro, M.Carolina.Accioly.; Rezende, Aônio.Mauro.; Pereira, Véria.Rêgo., 2014:
Targeting Dendritic Cells as a Good Alternative to Combat Leishmania spp

Mooneyham, A.; Bazzaro, M., 2016:
Targeting Deubiquitinating Enzymes and Autophagy in Cancer

Jin, W-Lin.; Mao, X-Yuan.; Qiu, G-Zhong., 2016:
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges

Pallayova, M.; Taheri, S., 2014:
Targeting Diabetes Distress: The Missing Piece of the Successful Type 1 Diabetes Management Puzzle

Ortore, G.; Orlandini, E.; Braca, A.; Ciccone, L.; Rossello, A.; Martinelli, A.; Nencetti, S., 2017:
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds

Anonymous, 2016:
Targeting Dihydroorotate Dehydrogenase Induces Differentiation in AML

Ordog, T.; Zörnig, M.; Hayashi, Y., 2015:
Targeting Disease Persistence in Gastrointestinal Stromal Tumors

Anonymous, 2016:
Targeting Disease through Metabolism

Abuhamdah, S.; Khalil, A.; Sari, Y., 2017:
Targeting Dopaminergic System for Treating Nicotine Dependence

Engel, J.; Richters, Aé.; Getlik, Mäus.; Tomassi, S.; Keul, M.; Termathe, M.; Lategahn, J.; Becker, C.; Mayer-Wrangowski, S.; Grütter, C.; Uhlenbrock, N.; Krüll, J.; Schaumann, N.; Eppmann, S.; Kibies, P.; Hoffgaard, F.; Heil, J.; Menninger, S.; Ortiz-Cuaran, S.; Heuckmann, J.M.; Tinnefeld, V.; Zahedi, Ré.P.; Sos, M.L.; Schultz-Fademrecht, C.; Thomas, R.K.; Kast, S.M.; Rauh, D., 2015:
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach

Chandra, P.; Rajmani, R.S.; Verma, G.; Bhavesh, N.Sarovar.; Kumar, D., 2016:
Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology

Cattaneo, D.; Jonsdottir, J.; Coote, S., 2015:
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network

Gao, D.; Yang, J.; Wu, Y.; Wang, Q.; Wang, Q.; Lai, E.Yin.; Zhu, J., 2016:
Targeting Dynamin 2 as a Novel Pathway to Inhibit Cardiomyocyte Apoptosis Following Oxidative Stress

Sarhan, R.Ahmed.; Aboelenein, H.Ragaee.Abdelhakam.; Sourour, S.Karim.Nasry.; Fawzy, I.Omar.; Salah, S.; Abdelaziz, A.Ihab., 2016:
Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients

Venning, F.A.; Wullkopf, L.; Erler, J.T., 2015:
Targeting ECM Disrupts Cancer Progression

Seshacharyulu, P.; Ponnusamy, M.P.; Rachagani, S.; Lakshmanan, I.; Haridas, D.; Yan, Y.; Ganti, A.K.; Batra, S.K., 2016:
Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer

Steuer, C.E.; Ramalingam, S.S., 2016:
Targeting EGFR in lung cancer: Lessons learned and future perspectives

Caiazza, F.; Elliott, L.; Fennelly, D.; Sheahan, K.; Doherty, G.A.; Ryan, E.J., 2016:
Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies

Haddad, F.G.; Kourie, H.R.; Kattan, J., 2016:
Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives

Horn, D.; Hess, J.; Freier, K.; Hoffmann, Jürgen.; Freudlsperger, C., 2016:
Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

Elkamhawy, A.; Farag, A.Karam.; Viswanath, A.Nath.Indu.; Bedair, T.M.; Leem, D.Gyu.; Lee, K-Tae.; Pae, A.Nim.; Roh, E.Joo., 2016:
Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular docking

Morán, T.; Quiroga, V.; Gil, Mía.de.Los.Llanos.; Vilà, L.; Pardo, N.; Carcereny, E.; Capdevila, L.; Muñoz-Mármol, A.M.; Rosell, R., 2013:
Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)

Hsieh, Y-Hsien.; Hsieh, S-Ching.; Lee, C-Hsing.; Yang, S-Fa.; Cheng, C-Wen.; Tang, M-Ju.; Lin, C-Liang.; Lin, C-Liang.; Chou, R-Hwang., 2016:
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway

Bangel-Ruland, N.; Tomczak, K.; Weber, W-Michael., 2016:
Targeting ENaC as a Molecular Suspect in Cystic Fibrosis

Chen, Y.; Tang, Q.; Xiao, Q.; Yang, L.; Hann, S.S., 2016:
Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells

Rainville, N.; Jachimowicz, E.; Wojchowski, D.M., 2016:
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis

Shin, J-Ae.; Kim, L-Han.; Lee, S-Jeong.; Jeong, J.H.; Jung, J-Youn.; Lee, H.Nim.; Hong, I-Sun.; Cho, S-Dae., 2016:
Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer

Duensing, A., 2016:
Targeting ETV1 in gastrointestinal stromal tumors: tripping the circuit breaker in GIST?

Zhu, W-Si.; Tang, C-Mei.; Xiao, Z.; Zhu, J-Ning.; Lin, Q-Xiong.; Fu, Y-Heng.; Hu, Z-Qin.; Zhang, Z.; Yang, M.; Zheng, X-Long.; Wu, S-Lin.; Shan, Z-Xin., 2016:
Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts

Xu, B.; Konze, K.D.; Jin, J.; Wang, G.Greg., 2015:
Targeting EZH2 and PRC2 dependence as novel anticancer therapy

Han Li, C.; Chen, Y., 2016:
Targeting EZH2 for cancer therapy: progress and perspective

Zhou, X.; Ren, Y.; Kong, L.; Cai, G.; Sun, S.; Song, W.; Wang, Y.; Jin, R.; Qi, L.; Mei, M.; Wang, X.; Kang, C.; Li, M.; Zhang, L., 2016:
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC

Humphreys, B.D.; Cantaluppi, V.; Portilla, D.; Singbartl, K.; Yang, L.; Rosner, M.H.; Kellum, J.A.; Ronco, C.; Okusa, M.; Rosner, M.H.; Kellum, J.A.; Ronco, C.; Agarwal, A.; Basile, D.P.; Blantz, R.; Bonventre, J.V.; Chawla, L.S.; Dong, Z.; Griffin, M.; Harris, R.; Ince, C.; Matejovic, M.; McKay, D.; Mehta, R.; Molitoris, B.; Murray, P.; Nangaku, M.; Pickkers, P.; Rabb, H.; Swaminathan, S.; Unwin, R.; Humphreys, B.D.; Cantaluppi, V.; Portilla, D.; Singbartl, K.; Yang, L., 2016:
Targeting Endogenous Repair Pathways after AKI

Ashander, L.M.; Appukuttan, B.; Ma, Y.; Gardner-Stephen, D.; Smith, J.R., 2016:
Targeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept Study

Marchesi, I.; Bagella, L., 2016:
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment

Smith, C.A.; Mont, S.; Traver, G.; Sekhar, K.R.; Crooks, P.A.; Freeman, M.L., 2016:
Targeting Enox1 in tumor stroma increases the efficacy of fractionated radiotherapy

Khalifa, L.; Brosh, Y.; Gelman, D.; Coppenhagen-Glazer, S.; Beyth, S.; Poradosu-Cohen, R.; Que, Y-Ai.; Beyth, N.; Hazan, R., 2015:
Targeting Enterococcus faecalis biofilms with phage therapy

Mercurio, F.A.; Marasco, D.; D.N.tale, C.; Pirone, L.; Costantini, S.; Pedone, E.M.; Leone, M., 2016:
Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues

Philip, P.A.; Lutz, M.P., 2016:
Targeting Epidermal Growth Factor Receptor-Related Signaling Pathways in Pancreatic Cancer

Ligon, C.O.; Moloney, R.D.; Greenwood-Van Meerveld, B., 2016:
Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics

Wachowska, M.; Muchowicz, A.; Golab, J., 2015:
Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity

Sun, M-Ge.; Shi, J-Feng.; Li, X-Ying.; Zhao, Y.; Ju, R-Jun.; Mu, L-Min.; Yan, Y.; Li, X-Tao.; Zeng, F.; Lu, W-Liang., 2015:
Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer

Du, B.; Shim, J.Sup., 2017:
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Polireddy, K.; Dong, R.; McDonald, P.R.; Wang, T.; Luke, B.; Chen, P.; Broward, M.; Roy, A.; Chen, Q., 2016:
Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation

Lai, J.; Tan, W.Jian.; Too, C.Tei.; Choo, J.Ai.Ling.; Wong, L.Hiong.; Mustafa, F.Bte.; Srinivasan, N.; Lim, A.Pei.Chiew.; Zhong, Y.; Gascoigne, N.R.J.; Hanson, B.J.; Chan, S.Ha.; Chen, J.; MacAry, P.A., 2017:
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities

McCall, L-Isobel.; E.A.oussi, A.; Choi, J.Yong.; Vieira, D.F.; D.M.ylder, G.; Johnston, J.B.; Chen, S.; Kellar, D.; Siqueira-Neto, J.L.; Roush, W.R.; Podust, L.M.; McKerrow, J.H., 2015:
Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase

Wisinski, K.B.; Xu, W.; Tevaarwerk, A.J.; Saha, S.; Kim, K.; Traynor, A.; Dietrich, L.; Hegeman, R.; Patel, D.; Blank, J.; Harter, J.; Burkard, M.E., 2017:
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study

Hamilton, D.H.; Griner, L.Mathews.; Keller, J.M.; Hu, X.; Southall, N.; Marugan, J.; David, J.M.; Ferrer, M.; Palena, C., 2016:
Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer

Béraud, C.; Dormoy, Vérian.; Danilin, S.; Lindner, Véronique.; Béthry, A.; Hochane, Mène.; Coquard, C.; Barthelmebs, M.; Jacqmin, D.; Lang, Hé.; Massfelder, T., 2015:
Targeting FAK scaffold functions inhibits human renal cell carcinoma growth

Abdel-Rahman, O., 2016:
Targeting FGF receptors in colorectal cancer: from bench side to bed side

Panera, N.; Ceccarelli, S.; Nobili, V.; Alisi, A., 2015:
Targeting FGF19 binding to its receptor system: a novel therapeutic approach for hepatocellular carcinoma

Jo, J-Cheol.; Choi, E.Kyoung.; Shin, J-Sik.; Moon, J-Hee.; Hong, S-Woo.; Lee, H-Reum.; Kim, S-Mi.; Jung, S-A.; Lee, D-Hee.; Jung, S.Hwan.; Lee, S-Hye.; Kim, J.Eun.; Kim, K-pyo.; Hong, Y.Sang.; Suh, Y-Ah.; Jang, S.Jin.; Choi, E.Kyung.; Lee, J.Shin.; Jin, D-Hoon.; Kim, T.Won., 2016:
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity

Touat, M.; Ileana, E.; Postel-Vinay, S.; André, F.; Soria, J-Charles., 2016:
Targeting FGFR Signaling in Cancer

Tsimafeyeu, I.; Ludes-Meyers, J.; Stepanova, E.; Daeyaert, F.; Khochenkov, D.; Joose, J-Baptiste.; Solomko, E.; Van Akene, K.; Peretolchina, N.; Yin, W.; Ryabaya, O.; Byakhov, M.; Tjulandin, S., 2017:
Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models

Dany, M.; Gencer, S.; Nganga, R.; Thomas, R.J.; Oleinik, N.; Baron, K.D.; Szulc, Z.M.; Ruvolo, P.; Kornblau, S.; Andreeff, M.; Ogretmen, B., 2016:
Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML

Ting, C-Hung.; Chen, Y-Chun.; Wu, C-Jer.; Chen, J-Yih., 2016:
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer

Gartel, A.L., 2015:
Targeting FOXM1 auto-regulation in cancer

Dansen, T.B.; Kalkhoven, E., 2015:
Targeting FOXO1 as an option to treat obesity?

Quarta, A.; Bernareggi, D.; Benigni, F.; Luison, E.; Nano, G.; Nitti, S.; Cesta, M.Candida.; D.C.ccio, L.; Canevari, S.; Pellegrino, T.; Figini, M., 2015:
Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo

Hsu, I-Ling.; Chou, C-Yang.; Wu, Y-Ying.; Wu, J-En.; Liang, C-Hsien.; Tsai, Y-Tsung.; Ke, J-Yu.; Chen, Y-Ling.; Hsu, K-Fu.; Hong, T-Ming., 2016:
Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma

Kory, N.; Farese, R.V.; Walther, T.C., 2017 :
Targeting Fat: Mechanisms of Protein Localization to Lipid Droplets

Ward, E.Sally.; Devanaboyina, S.Charan.; Ober, R.J., 2015:
Targeting FcRn for the modulation of antibody dynamics

Yu, X.; Lazarus, A.H., 2016:
Targeting FcγRs to treat antibody-dependent autoimmunity

Eneli, I.U.; Tylka, T.L.; Watowicz, R.P.; Hummel, J.; Ritter, J.; Lumeng, J.C., 2016:
Targeting Feeding and Eating Behaviors: Development of the Feeding Dynamic Intervention for Caregivers of 2- to 5-Year-Old Children

Schmidt, K.; Moser, C.; Hellerbrand, C.; Zieker, D.; Wagner, C.; Redekopf, J.; Schlitt, H.J.; Geissler, E.K.; Lang, S.A., 2016:
Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model

Nett, J.E.; Cabezas-Olcoz, J.; Marchillo, K.; Mosher, D.F.; Andes, D.R., 2017:
Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms

O'Connell, E.M.; Bennuru, S.; Steel, C.; Dolan, M.A.; Nutman, T.B., 2015:
Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal

Waters, A.M.; Stafman, L.L.; Garner, E.F.; Mruthyunjayappa, S.; Stewart, J.E.; Mroczek-Musulman, E.; Beierle, E.A., 2016:
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells

François, R.A.; Maeng, K.; Nawab, A.; Kaye, F.J.; Hochwald, S.N.; Zajac-Kaye, M., 2015:
Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors

Yu, C.; Chen, L.; Yie, L.; Wei, L.; Wen, T.; Liu, Y.; Chen, H., 2016 :
Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway

Tüfekçi, Özlem.; Yandım, M.Kartal.; Ören, H.; İrken, Gülersu.; Baran, Y., 2015:
Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line

Zou, P.; Liu, L.; Zheng, L.; Liu, L.; Stoneman, R.E.; Cho, A.; Emery, A.; Gilbert, E.R.; Cheng, Z., 2015:
Targeting FoxO1 with AS1842856 suppresses adipogenesis

Proctor, R.H.; Vaughan, M.M., 2018:
Targeting Fumonisin Biosynthetic Genes

Wylie, K.P.; Smucny, J.; Legget, K.T.; Tregellas, J.R., 2016:
Targeting Functional Biomarkers in Schizophrenia with Neuroimaging

Callahan, C.M.; Boustani, M.A.; Schmid, A.A.; LaMantia, M.A.; Austrom, M.G.; Miller, D.K.; Gao, S.; Ferguson, D.Y.; Lane, K.A.; Hendrie, H.C., 2016:
Targeting Functional Decline in Alzheimer Disease: A Randomized Trial

Sasser, T.; Schoenfelder, E.N.; Stein, M.A., 2016:
Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD

Crespo-Sempere, A.; Estiarte, N.; Marín, S.; Sanchis, V.; Ramos, A.J., 2015:
Targeting Fusarium graminearum control via polyamine enzyme inhibitors and polyamine analogs

Schwed, A.C.; de Virgilio, C., 2016:
Targeting Future Health Care Expenditure Reductions

Ghanemi, A., 2015:
Targeting G protein coupled receptor-related pathways as emerging molecular therapies

Porru, M.; Artuso, S.; Salvati, E.; Bianco, A.; Franceschin, M.; Diodoro, M.Grazia.; Passeri, D.; Orlandi, A.; Savorani, F.; D'Incalci, M.; Biroccio, A.; Leonetti, C., 2016:
Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer

Xiong, Y-Xia.; Huang, Z-Shu.; Tan, J-Heng., 2016:
Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives

Bhasikuttan, A.C.; Mohanty, J., 2016:
Targeting G-quadruplex structures with extrinsic fluorogenic dyes: promising fluorescence sensors

Miletta, M.Consolata.; Flück, C.E.; Mullis, P-E., 2016:
Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II

Zhang, R.; Wu, J.; Ferrandon, S.; Glowacki, K.J.; Houghton, J.A., 2016:
Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing

Infante, P.; Alfonsi, R.; Botta, B.; Mori, M.; D.M.rcotullio, L., 2016:
Targeting GLI factors to inhibit the Hedgehog pathway

Hadden, M.Kyle., 2015:
Targeting GLI proteins in human cancer by small molecules (WO2014116651 A1): a patent evaluation

Long, B.; Wang, L-Xun.; Zheng, F-Meng.; Lai, S-Ping.; Xu, D-Rong.; Hu, Y.; Lin, D-Jun.; Zhang, X-Zhong.; Dong, L.; Long, Z-Jie.; Tong, X-Zhen.; Liu, Q., 2016:
Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells

McNamee, E.N.; Biette, K.A.; Hammer, J.; Harris, R.; Miyazawa, H.; Lee, J.J.; Furuta, G.T.; Masterson, J.C., 2016:
Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis

Avci, A.Berkant.; Feist, E.; Burmester, G-Rüdiger., 2016:
Targeting GM-CSF in rheumatoid arthritis

Martínez-Bosch, N.; Navarro, P., 2015:
Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard

Paulmichl, A.; Summer, D.; Manzl, C.; Rangger, C.; Orlandi, F.; Niedermoser, S.; Taguchi, T.; Wängler, Börn.; Decristoforo, C., 2016:
Targeting Gastrointestinal Stromal Tumor with 68 Ga-Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines

Durieux, A.M.S.; Fernandes, C.; Murphy, D.; Labouesse, M.Anais.; Giovanoli, S.; Meyer, U.; Li, Q.; So, P-Wah.; McAlonan, G., 2015:
Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice

Li, L.; Stary, C.M., 2016:
Targeting Glial Mitochondrial Function for Protection from Cerebral Ischemia: Relevance, Mechanisms, and the Role of MicroRNAs

Pistollato, F.; Bremer-Hoffmann, S.; Basso, G.; Cano, S.Sumalla.; Elio, Iñaki.; Vergara, M.Masias.; Giampieri, F.; Battino, M., 2015:
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles

Karki, K.; Ewing, J.R.; Ali, M.M., 2016:
Targeting Glioma with a Dual Mode Optical and Paramagnetic Nanoprobe across the Blood-brain Tumor Barrier

Pinheiro, R.; Braga, Cáudia.; Santos, G.; Bronze, M.R.; Perry, M.J.; Moreira, R.; Brites, D.; Falcão, A.S., 2016:
Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?

Rosenberg, S.A.; Niglio, S.A.; Salehomoum, N.; Chan, J.L-K.; Jeong, B-Seon.; Wen, Y.; Li, J.; Fukui, J.; Chen, S.; Shin, S-Shick.; Goydos, J.S., 2015:
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression

Chen, L.; Cui, H., 2016:
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach

Korangath, P.; Teo, W.Wen.; Sadik, H.; Han, L.; Mori, N.; Huijts, C.M.; Wildes, F.; Bharti, S.; Zhang, Z.; Santa-Maria, C.A.; Tsai, H.; Dang, C.V.; Stearns, V.; Bhujwalla, Z.M.; Sukumar, S., 2016:
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate

Macrae, D., 2016:
Targeting Glycemic Control After Pediatric Cardiac Surgery

Kanthimathinathan, H.Krishnan.; Sundararajan, S.B.; Laker, S.; Scholefield, B.R.; Morris, K.P., 2016:
Targeting Glycemic Control After Pediatric Cardiac Surgery: The Influence of Age on Insulin Requirement

Roth, M.; Barris, D.M.; Piperdi, S.; Kuo, V.; Everts, S.; Geller, D.; Houghton, P.; Kolb, E.Anders.; Hawthorne, T.; Gill, J.; Gorlick, R., 2016:
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma

Shayman, J.A., 2016:
Targeting Glycosphingolipid Metabolism to Treat Kidney Disease

Wang, L.; Sun, Y.; Yi, J.; Wang, X.; Liang, J.; Pan, Z.; Li, L.; Jiang, G., 2016:
Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion

Andl, C.D., 2015:
Targeting HCC Therapy: On or Off ToPiX?

Anonymous, 2016:
Targeting HDAC And PI3K Inhibits MYC-Driven Medulloblastoma Growth

Zhang, J.; Saba, N.F.; Chen, G.Zhuo.; Shin, D.M., 2016:
Targeting HER (ERBB) signaling in head and neck cancer: An essential update

Jomrich, G.; Schoppmann, S.F., 2016:
Targeting HER 2 and angiogenesis in gastric cancer

Monteiro, Iês.de.Paula.Costa.; Madureira, P.; de Vasconscelos, A.; Pozza, D.Humberto.; de Mello, R.Andrade., 2015:
Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies

Bhat, M.Ahmad.; Al-Dhfyan, A.; Khan, A.Ali.; Al-Harbi, N.; Manogaran, P.S.; Alanazi, A.M.; Fun, H-Kun.; Al-Omar, M.A., 2015:
Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide

Wahler, J.; Suh, N., 2015:
Targeting HER2 Positive Breast Cancer with Chemopreventive Agents

Kris, M.G.; Camidge, D.R.; Giaccone, G.; Hida, T.; Li, B.T.; O'Connell, J.; Taylor, I.; Zhang, H.; Arcila, M.E.; Goldberg, Z.; Jänne, P.A., 2016:
Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

Rimawi, M.F.; Schiff, R.; Osborne, C.Kent., 2015:
Targeting HER2 for the treatment of breast cancer

Mar, N.; Vredenburgh, J.J.; Wasser, J.S., 2015:
Targeting HER2 in the treatment of non-small cell lung cancer

Hayashi, T.; Seiler, R.; Oo, H.Zarni.; Jäger, W.; Moskalev, I.; Awrey, S.; Dejima, T.; Todenhöfer, T.; Li, N.; Fazli, L.; Matsubara, A.; Black, P.C., 2015:
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer

Jiang, Z.; Liu, J.C.; Chung, P.E.D.; Egan, S.E.; Zacksenhaus, E., 2015:
Targeting HER2(+) breast cancer: the TBK1/IKKε axis

Schmoll, H-Joachim., 2016:
Targeting HER2: precision oncology for colorectal cancer

Malm, M.; Frejd, F.Y.; Ståhl, S.; Löfblom, J., 2016:
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds

Dai, L.; Trillo-Tinoco, J.; Cao, Y.; Bonstaff, K.; Doyle, L.; Del Valle, L.; Whitby, D.; Parsons, C.; Reiss, K.; Zabaleta, J.; Qin, Z., 2016:
Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Vyas, P., 2015:
Targeting HIF function: the debate continues

Chen, J.; Lai, L.; Liu, S.; Zhou, C.; Wu, C.; Huang, M.; Lin, Q., 2016:
Targeting HIF-1α and VEGF by lentivirus-mediated RNA interference reduces liver tumor cells migration and invasion under hypoxic conditions

Hong, S-Eun.; Jin, H-Ok.; Kim, H-Ah.; Seong, M-Ki.; Kim, E-Kyu.; Ye, S-Kyu.; Choe, T-Boo.; Lee, J.Kyung.; Kim, J-Il.; Park, I-Chul.; Noh, W.Chul., 2016:
Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin

Ahn, S-Hyun.; Choi, J.Yeon.; Kim, D.Wook.; Lee, D.Young.; Jeon, E-Hui.; Jeong, W-Jin.; Paik, J.Ho., 2016:
Targeting HIF1α peri-operatively increased post-surgery survival in a tongue cancer animal model

Ricketts, C.J.; Crooks, D.R.; Linehan, W.Marston., 2017:
Targeting HIF2α in Clear-Cell Renal Cell Carcinoma

Wang, X.; Wu, Y.; Mao, L.; Xia, W.; Zhang, W.; Dai, L.; Mehta, S.R.; Wertheim, J.O.; Dong, X.; Zhang, T.; Wu, H.; Smith, D.M., 2016:
Targeting HIV Prevention Based on Molecular Epidemiology Among Deeply Sampled Subnetworks of Men Who Have Sex With Men

Sloan, D.D.; Lam, C-Ying.Kao.; Irrinki, A.; Liu, L.; Tsai, A.; Pace, C.S.; Kaur, J.; Murry, J.P.; Balakrishnan, M.; Moore, P.A.; Johnson, S.; Nordstrom, J.L.; Cihlar, T.; Koenig, S., 2016:
Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells

Kirby, T., 2016:
Targeting HIV prevention to young women in Africa

Klein, D.J.; Eckhoff, P.A.; Bershteyn, A., 2015:
Targeting HIV services to male migrant workers in southern Africa would not reverse generalized HIV epidemics in their home communities: a mathematical modeling analysis

Mousseau, G.; Mediouni, S.; Valente, S.T., 2015:
Targeting HIV transcription: the quest for a functional cure

Zurawski, G.; Zurawski, S.; Flamar, A-Laure.; Richert, L.; Wagner, R.; Tomaras, G.D.; Montefiori, D.C.; Roederer, M.; Ferrari, G.; Lacabaratz, C.; Bonnabau, H.; Klucar, P.; Wang, Z.; Foulds, K.E.; Kao, S-Fen.; Yates, N.L.; LaBranche, C.; Jacobs, B.L.; Kibler, K.; Asbach, B.; Kliche, A.; Salazar, A.; Reed, S.; Self, S.; Gottardo, R.; Galmin, L.; Weiss, D.; Cristillo, A.; Thiebaut, R.; Pantaleo, G.; Levy, Y., 2016:
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

Li, Y.; Xuan, S.; Feng, Y.; Yan, A., 2016:
Targeting HIV-1 integrase with strand transfer inhibitors

Nalini, V.; Deepa, P.Ravi.; Raguraman, R.; Khetan, V.; Reddy, M.Ashwin.; Krishnakumar, S., 2016:
Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy

Gao, Z.; Han, Y.; Hu, Y.; Wu, X.; Wang, Y.; Zhang, X.; Fu, J.; Zou, X.; Zhang, J.; Chen, X.; Jose, P.A.; Lu, X.; Zeng, C., 2016:
Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways

Kong, L.; Zhou, X.; Wu, Y.; Wang, Y.; Chen, L.; Li, P.; Liu, S.; Sun, S.; Ren, Y.; Mei, M.; Wang, X.; Zhang, L., 2016:
Targeting HOTAIR Induces Mitochondria Related Apoptosis and Inhibits Tumor Growth in Head and Neck Squamous Cell Carcinoma in vitro and in vivo

Ganguly, S.; Home, T.; Yacoub, A.; Kambhampati, S.; Shi, H.; Dandawate, P.; Padhye, S.; Saluja, A.K.; McGuirk, J.; Rao, R., 2016:
Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia

Asling, J.; Morrison, J.; Mutsaers, A.J., 2016:
Targeting HSP70 and GRP78 in canine osteosarcoma cells in combination with doxorubicin chemotherapy

Lazaro, I.; Oguiza, A.; Recio, C.; Mallavia, Bñat.; Madrigal-Matute, J.; Blanco, J.; Egido, J.; Martin-Ventura, J-Luis.; Gomez-Guerrero, C., 2016:
Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice

Mellatyar, H.; Talaei, S.; Nejati-Koshki, K.; Akbarzadeh, A., 2016:
Targeting HSP90 Gene Expression with 17-DMAG Nanoparticles in Breast Cancer Cells

Venkatesan, N.; Kanwar, J.R.; Deepa, P.Ravi.; Navaneethakrishnan, S.; Joseph, C.; Krishnakumar, S., 2016:
Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma

Birkeland, A.C.; Owen, J.H.; Prince, M.E., 2016:
Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges

McGrady, M.E.; Hommel, K.A., 2017:
Targeting Health Behaviors to Reduce Health Care Costs in Pediatric Psychology: Descriptive Review and Recommendations

Ashwinder, K.; Kho, M.Teck.; Chee, P.Mun.; Lim, W.Zhuan.; Yap, I.K.S.; Choi, S.Bing.; Yam, W.Keat., 2015:
Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach

Ogilvie, H.; Cacciani, N.; Akkad, H.; Larsson, L., 2016:
Targeting Heat Shock Proteins Mitigates Ventilator Induced Diaphragm Muscle Dysfunction in an Age-Dependent Manner

Proia, D.A.; Kaufmann, G.F., 2016:
Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy

Ghia, P., 2016:
Targeting Hedgehog in haematological malignancies

Zeng, X.; Zhao, H.; Li, Y.; Fan, J.; Sun, Y.; Wang, S.; Wang, Z.; Song, P.; Ju, D., 2016:
Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia

Jiang, B.; Suen, R.; Wertheim, J.A.; Ameer, G.A., 2017:
Targeting Heparin to Collagen within Extracellular Matrix Significantly Reduces Thrombogenicity and Improves Endothelialization of Decellularized Tissues

Montano-Loza, A.J.; Thandassery, R.B.; Czaja, A.J., 2016:
Targeting Hepatic Fibrosis in Autoimmune Hepatitis

Barter, P.J.; Rye, K-Anne., 2016:
Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?

Dutkiewicz, M.; Ojdowska, A.; Kuczynski, J.; Lindig, V.; Zeichhardt, H.; Kurreck, J.; Ciesiołka, J., 2016:
Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells

Moiseeva, E.D.; Bazhulina, N.P.; Gursky, Y.G.; Grokhovsky, S.L.; Surovaya, A.N.; Gursky, G.V., 2016:
Targeting Holliday junctions by origin DNA-binding protein of herpes simplex virus type 1

Vignali, D.; Monti, P., 2016:
Targeting Homeostatic T Cell Proliferation to Control Beta-Cell Autoimmunity

Berte, N.; Piée-Staffa, A.; Piecha, N.; Wang, M.; Borgmann, K.; Kaina, B.; Nikolova, T., 2016:
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs

Deng, X.; Michaelson, D.; Tchieu, J.; Cheng, J.; Rothenstein, D.; Feldman, R.; Lee, S-gyu.; Fuller, J.; Haimovitz-Friedman, A.; Studer, L.; Powell, S.; Fuks, Z.; Hubbard, E.Jane.Albert.; Kolesnick, R., 2016:
Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors

Tamaki, H.; Reguera, M.; Abdel-Tawab, Y.M.; Takebayashi, Y.; Kasahara, H.; Blumwald, E., 2016:
Targeting Hormone-Related Pathways to Improve Grain Yield in Rice: A Chemical Approach

Noubiap, J.Jacques.N.; Essouma, M.; Bigna, J.Joel.R., 2016:
Targeting Household Air Pollution for Curbing the Cardiovascular Disease Burden: A Health Priority in Sub-Saharan Africa

Kumar, S.; Stokes, J.; Singh, U.P.; Scissum Gunn, K.; Acharya, A.; Manne, U.; Mishra, M., 2016:
Targeting Hsp70: A possible therapy for cancer

Woodford, M.R.; Dunn, D.M.; Ciciarelli, J.G.; Beebe, K.; Neckers, L.; Mollapour, M., 2017:
Targeting Hsp90 in Non-Cancerous Maladies

Chehab, M.; Caza, T.; Skotnicki, K.; Landas, S.; Bratslavsky, G.; Mollapour, M.; Bourboulia, D., 2016:
Targeting Hsp90 in urothelial carcinoma

Wang, L.; Li, L.; Gu, K.; Xu, X-Li.; Sun, Y.; You, Q-Dong., 2016:
Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function

Zhang, M.; He, J.; Yang, J., 2016:
Targeting Human iβ -Microglobulin with Monoclonal Antibodies in Multiple Myeloma - A Potential in Treatment

Salanti, A.; Clausen, T.M.; Agerbæk, M.Ø.; Al Nakouzi, N.; Dahlbäck, M.; Oo, H.Z.; Lee, S.; Gustavsson, T.; Rich, J.R.; Hedberg, B.J.; Mao, Y.; Barington, L.; Pereira, M.A.; LoBello, J.; Endo, M.; Fazli, L.; Soden, J.; Wang, C.K.; Sander, A.F.; Dagil, R.; Thrane, S.; Holst, P.J.; Meng, L.; Favero, F.; Weiss, G.J.; Nielsen, M.A.; Freeth, J.; Nielsen, T.O.; Zaia, J.; Tran, N.L.; Trent, J.; Babcook, J.S.; Theander, T.G.; Sorensen, P.H.; Daugaard, M., 2016:
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

Theis, M.; Paszkowski-Rogacz, M.; Weisswange, I.; Chakraborty, D.; Buchholz, F., 2016:
Targeting Human Long Noncoding Transcripts by Endoribonuclease-Prepared siRNAs

Song, M.; Li, J-Lan.; Li, X-Ping.; Kan, S-Feng., 2015:
Targeting Human Poly(ADP-Ribose) Polymerase-1 with Natural Medicines and Its Potential Applications in Ovarian Cancer Therapeutics

Xu, H.; Gong, X.; Zhang, H.Hui.; Zhang, Q.; Zhao, D.; Peng, J.Xiong., 2015:
Targeting Human Telomerase Reverse Transcriptase by a Simple siRNA Expression Cassette in HepG2 Cells

Nilsson, S.K.; Childs, L.M.; Buckee, C.; Marti, M., 2016:
Targeting Human Transmission Biology for Malaria Elimination

Zhu, H.; Liu, J.; Cui, C.; Song, Y.; Ge, H.; Hu, L.; Li, Q.; Jin, Y.; Zhang, Y., 2016:
Targeting Human α-Lactalbumin Gene Insertion into the Goat β-Lactoglobulin Locus by TALEN-Mediated Homologous Recombination

Nigim, F.; Cavanaugh, J.; Patel, A.P.; Curry, W.T.; Esaki, S-ichi.; Kasper, E.M.; Chi, A.S.; Louis, D.N.; Martuza, R.L.; Rabkin, S.D.; Wakimoto, H., 2015:
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment

Fulda, S., 2016:
Targeting IAP proteins in combination with radiotherapy

Sumida, T.; Ishikawa, A.; Nakano, H.; Yamada, T.; Mori, Y.; Desprez, P-Yves., 2016:
Targeting ID2 expression triggers a more differentiated phenotype and reduces aggressiveness in human salivary gland cancer cells

Eslam, M.; George, J., 2016:
Targeting IFN-λ: therapeutic implications

Ghali, J.R.; Holdsworth, S.R.; Kitching, A.Richard., 2016:
Targeting IL-17 and IL-23 in Immune Mediated Renal Disease

Kim, B-Seok.; Park, Y-Jun.; Chung, Y., 2016:
Targeting IL-17 in autoimmunity and inflammation

Dyring-Andersen, B.; Skov, L.; Zachariae, C., 2016:
Targeting IL-17 with ixekizumab in patients with psoriasis

Wynn, J.Lawrence.; Wilson, C.S.; Hawiger, J.; Scumpia, P.O.; Marshall, A.F.; Liu, J-Hua.; Zharkikh, I.; Wong, H.R.; Lahni, P.; Benjamin, J.T.; Plosa, E.J.; Weitkamp, Jörn-Hendrik.; Sherwood, E.R.; Moldawer, L.L.; Ungaro, R.; Baker, H.V.; Lopez, M.Cecilia.; McElroy, S.J.; Colliou, N.; Mohamadzadeh, M.; Moore, D.Jensen., 2016:
Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18

Wu, H-Hsiung.; Hwang-Verslues, W.W.; Lee, W-Hsin.; Huang, C-Kai.; Wei, P-Chi.; Chen, C-Lin.; Shew, J-Yuh.; Lee, E.Y-H.P.; Jeng, Y-Ming.; Tien, Y-Wen.; Ma, C.; Lee, W-Hwa., 2015:
Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines

Lee, M.; Kim, D.Woo.; Shin, H-Woo., 2016:
Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps

Theoharides, T.C.; Petra, A.I.; Taracanova, A.; Panagiotidou, S.; Conti, P., 2015:
Targeting IL-33 in autoimmunity and inflammation

Karjalainen, K.; Jaalouk, D.E.; Bueso-Ramos, C.; Bover, L.; Sun, Y.; Kuniyasu, A.; Driessen, W.H.P.; Cardó-Vila, M.; Rietz, C.; Zurita, A.J.; O'Brien, S.; Kantarjian, H.M.; Cortes, J.E.; Calin, G.A.; Koivunen, E.; Arap, W.; Pasqualini, R., 2016:
Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens

Papageorgis, P.; Ozturk, S.; Lambert, A.W.; Neophytou, C.M.; Tzatsos, A.; Wong, C.K.; Thiagalingam, S.; Constantinou, A.I., 2016:
Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

Bankaitis, K.Venmar.; Fingleton, B., 2016:
Targeting IL4/IL4R for the treatment of epithelial cancer metastasis

Dussiau, C.; Trinquand, Aélie.; Lhermitte, L.; Latiri, M.; Simonin, M.; Cieslak, A.; Bedjaoui, N.; Villarèse, P.; Verhoeyen, E.; Dombret, Hé.; Ifrah, N.; Macintyre, E.; Asnafi, V., 2016:
Targeting IRAK1 in T-cell acute lymphoblastic leukemia

Zink, A.; Gensbaur, A.; Zirbs, M.; Seifert, F.; Suarez, I.Leon.; Mourantchanian, V.; Weidinger, S.; Mempel, M.; Ring, J.; Ollert, M., 2016:
Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab

Yan, C.; Gao, N.; Sun, H.; Yin, J.; Lee, P.; Zhou, L.; Fan, X.; Yu, F-Shin., 2017:
Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas

Alatrash, G.; Daver, N.; Mittendorf, E.A., 2016 :
Targeting Immune Checkpoints in Hematologic Malignancies

Camisaschi, C.; Vallacchi, V.; Vergani, E.; Tazzari, M.; Ferro, S.; Tuccitto, A.; Kuchuk, O.; Shahaj, E.; Sulsenti, R.; Castelli, C.; Rodolfo, M.; Rivoltini, L.; Huber, V., 2016:
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer

Anonymous, 2017:
Targeting Immune Suppression in Cancer

Resa-Infante, P.; Paterson, D.; Bonet, J.; Otte, A.; Oliva, B.; Fodor, E.; Gabriel, Gülsah., 2016:
Targeting Importin-α7 as a Therapeutic Approach against Pandemic Influenza Viruses

Simsekyilmaz, S.; Liehn, E.A.; Weinandy, S.; Schreiber, F.; Megens, R.T.A.; Theelen, W.; Smeets, R.; Jockenhövel, S.; Gries, T.; Möller, M.; Klee, D.; Weber, C.; Zernecke, A., 2017:
Targeting In-Stent-Stenosis with RGD- and CXCL1-Coated Mini-Stents in Mice

Knudsen, S.Haugaard.; Pedersen, B.Klarlund., 2016:
Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes

Todoric, J.; Antonucci, L.; Karin, M., 2016:
Targeting Inflammation in Cancer Prevention and Therapy

Mulay, S.R.; Holderied, A.; Kumar, S.V.; Anders, H-Joachim., 2016:
Targeting Inflammation in So-Called Acute Kidney Injury

Bottini, A.; De, S.K.; Wu, B.; Tang, C.; Varani, G.; Pellecchia, M., 2016:
Targeting Influenza A Virus RNA Promoter

Ashley, S.L.; Sisson, T.H.; Wheaton, A.K.; Kim, K.K.; Wilke, C.A.; Ajayi, I.O.; Subbotina, N.; Wang, S.; Duckett, C.S.; Moore, B.B.; Horowitz, J.C., 2016:
Targeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis

Toda, A.; Sawada, K.; Fujikawa, T.; Wakabayashi, A.; Nakamura, K.; Sawada, I.; Yoshimura, A.; Nakatsuka, E.; Kinose, Y.; Hashimoto, K.; Mabuchi, S.; Tokuhira, A.; Nakayama, M.; Itai, A.; Kurachi, H.; Kimura, T., 2016:
Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells

Pattabhi, S.; Wilkins, C.R.; Dong, R.; Knoll, M.L.; Posakony, J.; Kaiser, S.; Mire, C.E.; Wang, M.L.; Ireton, R.C.; Geisbert, T.W.; Bedard, K.M.; Iadonato, S.P.; Loo, Y-Ming.; Gale, M., 2016:
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway

Ultimo, A.; Giménez, C.; Bartovsky, P.; Aznar, E.; Sancenón, Félix.; Marcos, M.Dolores.; Amorós, P.; Bernardo, A.R.; Martínez-Máñez, Rón.; Jiménez-Lara, A.M.; Murguía, Jé.R., 2016:
Targeting Innate Immunity with dsRNA-Conjugated Mesoporous Silica Nanoparticles Promotes Antitumor Effects on Breast Cancer Cells

Chen, Y.; Zhang, J.; Zhang, B.; Gong, C-Xin., 2016:
Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

Tang, W-Jen., 2016:
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus

Marzec, K.A.; Baxter, R.C.; Martin, J.L., 2016:
Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer

Fløisand, Y.; Lundin, K.E.A.; Lazarevic, V.; Kristiansen, Jørn.Dehli.; Osnes, L.T.N.; Tjønnfjord, G.E.; Reims, H.Mikael.; Gedde-Dahl, T., 2016:
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease

Fiorucci, S.; Lin, X.; Sadoul, K.; Fournet, G.; Bouvard, D.; Vinogradova, O.; Joseph, Bît.; Block, M.R., 2016:
Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-2-Quinolone Derivatives: A new Class of Integrin Antagonists

Han, K.Seok.; Li, N.; Raven, P.A.; Fazli, L.; Ettinger, S.; Hong, S.Joon.; Gleave, M.E.; So, A.I., 2016:
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma

Levesque, B.G.; Ghosh, S., 2016:
Targeting Integrins and Safety in an Emerging Class of Targeted Oral Therapies: Are We Prepared for Rational and Precision Choices?

Qi, J.; Zhao, X-Fang.; Yu, X-Jing.; Yi, Q-Yue.; Shi, X-Lian.; Tan, H.; Fan, X-Yan.; Gao, H-Li.; Yue, L-Ying.; Feng, Z-Peng.; Kang, Y-Ming., 2015:
Targeting Interleukin-1 beta to Suppress Sympathoexcitation in Hypothalamic Paraventricular Nucleus in Dahl Salt-Sensitive Hypertensive Rats

Winship, A.L.; Van Sinderen, M.; Donoghue, J.; Rainczuk, K.; Dimitriadis, E., 2017:
Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo

Sager, H.B.; Heidt, T.; Hulsmans, M.; Dutta, P.; Courties, G.; Sebas, M.; Wojtkiewicz, G.R.; Tricot, B.; Iwamoto, Y.; Sun, Y.; Weissleder, R.; Libby, P.; Swirski, F.K.; Nahrendorf, M., 2016:
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction

Zhong, Y.; Johnson, A.J.; Byrd, J.C.; Dubovsky, J.A., 2014:
Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases

Czihal, M., 2016:
Targeting Interleukin-6 in the treatment of giant cell arteritis: hope or hype?

Mandal, C.C.; Rahman, M.Mizanur., 2015:
Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment

Anreddy, N.; Hazlehurst, L.A., 2016:
Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma

Radulovic, M.; Anand, P.; Korsten, M.A.; Gong, B., 2015:
Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord Injury

Saraon, T.; Katz, S.D., 2016:
Targeting Iron Deficiency Anemia in Heart Failure

Walker, V.J.; Agarwal, A., 2016:
Targeting Iron Homeostasis in Acute Kidney Injury

Akam, E.A.; Tomat, E., 2017:
Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators

Pascher, A., 2016:
Targeting Ischemia Reperfusion in Intestinal Transplantation by COX-2 Inhibition-A S.M.A.R.T Approach?

Cowan, A.; Kehner, G.B.; Inan, S., 2015:
Targeting Itch with Ligands Selective for κ Opioid Receptors

Zhang, Y.; Lapidus, R.G.; Liu, P.; Choi, E.Yong.; Adediran, S.; Hussain, A.; Wang, X.; Liu, X.; Dan, H.C., 2017:
Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA

Helsley, R.N.; Sui, Y.; Park, S-Hyung.; Liu, Z.; Lee, R.G.; Zhu, B.; Kern, P.A.; Zhou, C., 2017:
Targeting IκB kinase β in Adipocyte Lineage Cells for Treatment of Obesity and Metabolic Dysfunctions

Baan, C.C.; Kannegieter, N.M.; Felipe, C.Rosso.; Tedesco Silva, H., 2016:
Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation: A Reappraisal

Felices, M.; Miller, J.S., 2016:
Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

Ortiz-Romero, P.L., 2016:
Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas

Stahl, M.; Gedrich, R.; Peck, R.; LaVallee, T.; Eder, J.Paul., 2016:
Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors

Brito, H.; Martins, A.Cláudia.; Lavrado, Jão.; Mendes, E.; Francisco, A.Paula.; Santos, S.A.; Ohnmacht, S.A.; Kim, N-Soon.; Rodrigues, Cília.M.P.; Moreira, R.; Neidle, S.; Borralho, P.M.; Paulo, A., 2016:
Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives

Bournet, B.; Buscail, C.; Muscari, F.; Cordelier, P.; Buscail, L., 2016:
Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities

Zhang, J.; Park, D.; Shin, D.M.; Deng, X., 2015:
Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities

Levade, M.; Severin, S.; Gratacap, M-Pierre.; Ysebaert, Lïc.; Payrastre, B., 2016:
Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets

Gao, Y.; Ding, Y.; Chen, H.; Chen, H.; Zhou, J., 2015:
Targeting Krüppel-like factor 5 (KLF5) for cancer therapy

Lanthier, N., 2015:
Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Reeves, T.M.; Trimmer, P.A.; Colley, B.S.; Phillips, L.L., 2017:
Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Jin, S-Eon.; Jin, H-Eon.; Hong, S-Sun., 2016:
Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics

Sjödin, S.; Öhrfelt, A.; Brinkmalm, G.; Zetterberg, H.; Blennow, K.; Brinkmalm, A., 2016:
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

Junttila, M.R.; Mao, W.; Wang, X.; Wang, B-Er.; Pham, T.; Flygare, J.; Yu, S-Fan.; Yee, S.; Goldenberg, D.; Fields, C.; Eastham-Anderson, J.; Singh, M.; Vij, R.; Hongo, J-Anne.; Firestein, R.; Schutten, M.; Flagella, K.; Polakis, P.; Polson, A.G., 2016:
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer

Prunier, Cé.; Kapur, R.; Lafanechère, L., 2016:
Targeting LIM kinases in taxane resistant tumors

Pelosi, E.; Castelli, G.; Testa, U., 2016:
Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells

Zheng, X.; Cheng, M.; Fu, B.; Fan, X.; Wang, Q.; Yu, X.; Sun, R.; Tian, Z.; Wei, H., 2015:
Targeting LUNX inhibits non-small cell lung cancer growth and metastasis

Rhaiem, R.Ben.; Houimel, M., 2016:
Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library

Khanna, R.; Mosli, M.H.; Feagan, B.G., 2015:
Targeting Leukocyte Trafficking in Inflammatory Bowel Disease: What Is the Clinical Evidence?

Krug, L.M.; Milton, D.; Chen, L.; Jungbluth, A.A.; Quaia, E.; Nagel, A.; Jones, J.; Finn, R.; Divgi, C., 2016:
Targeting Lewis Y (LeY) in small cell lung cancer (SCLC) with a humanized monoclonal antibody, hu3S193

Hallsworth, K.; Avery, L.; Trenell, M.I., 2016:
Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature

Shearer, A.M.; Rana, R.; Austin, K.; Baleja, J.D.; Nguyen, N.; Bohm, A.; Covic, L.; Kuliopulos, A., 2016:
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin

Zhou, T.; Kim, Y.; MacLeod, A.Robert., 2016:
Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics

Sugihara, T.; Harigai, M., 2016:
Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs

Minassian, K.; McKay, W.Barry.; Binder, H.; Hofstoetter, U.S., 2016:
Targeting Lumbar Spinal Neural Circuitry by Epidural Stimulation to Restore Motor Function After Spinal Cord Injury

Yue, H.; Huang, D.; Qin, L.; Zheng, Z.; Hua, L.; Wang, G.; Huang, J.; Huang, H., 2016:
Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine

Wang, Q.; Rosa, B.A.; Nare, B.; Powell, K.; Valente, S.; Rotili, D.; Mai, A.; Marshall, G.R.; Mitreva, M., 2016:
Targeting Lysine Deacetylases (KDACs) in Parasites

Xu, S-Tao.; Ding, X.; Ni, Q-Feng.; Jin, S-Ju., 2016:
Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells

Demeyer, A.; Staal, J.; Beyaert, R., 2016:
Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?

Kyosseva, S.V., 2016:
Targeting MAPK Signaling in Age-Related Macular Degeneration

Abe, S.; Yamamoto, K.; Kurata, M.; Abe-Suzuki, S.; Horii, R.; Akiyama, F.; Kitagawa, M., 2016:
Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors

Warner, K.A.; Nör, F.; Acasigua, G.A.; Martins, M.D.; Zhang, Z.; McLean, S.A.; Spector, M.E.; Chepeha, D.B.; Helman, J.; Wick, M.J.; Moskaluk, C.A.; Castilho, R.M.; Pearson, A.T.; Wang, S.; Nör, J.E., 2016:
Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma

Cao, L.; Fan, L.; Xu, W.; Li, J-Yong., 2016:
Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

Linklater, E.S.; Tovar, E.A.; Essenburg, C.J.; Turner, L.; Madaj, Z.; Winn, M.E.; Melnik, M.K.; Korkaya, H.; Maroun, C.R.; Christensen, J.G.; Steensma, M.R.; Boerner, J.L.; Graveel, C.R., 2016:
Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

Charakidis, M.; Boyer, M., 2015:
Targeting MET and EGFR in NSCLC-what can we learn from the recently reported phase III trial of onartuzumab in combination with erlotinib in advanced non-small cell lung cancer?

Awad, A.J.; Burns, T.C.; Zhang, Y.; Abounader, R., 2015:
Targeting MET for glioma therapy

Drilon, A.; Cappuzzo, F.; Ou, S-Hong.Ignatius.; Camidge, D.Ross., 2016:
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

Landi, L.; Cappuzzo, F., 2015:
Targeting MET in NSCLC: looking for a needle in a haystack

Szewczyk, B.; Skrzypek, K.; Majka, M., 2015:
Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress

O'Reilly, C.; Doroudian, M.; Mawhinney, L.; Donnelly, S.C., 2016:
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities

Arozarena, I.; Smith, M.P.; Wellbrock, C., 2016:
Targeting MITF in the tolerance-phase

Maachani, U.Bhanu.; Kramp, T.; Hanson, R.; Zhao, S.; Celiku, O.; Shankavaram, U.; Colombo, R.; Caplen, N.J.; Camphausen, K.; Tandle, A., 2016:
Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins

de Lucas, A.G.; Schuhmacher, A.J.; Oteo, M.; Romero, E.; Cámara, J.A.; de Martino, A.; Arroyo, A.G.; Morcillo, M.Á.; Squatrito, M.; Martinez-Torrecuadrada, J.L.; Mulero, F., 2016:
Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas

Pikman, Y.; Puissant, A.; Alexe, G.; Furman, A.; Chen, L.M.; Frumm, S.M.; Ross, L.; Fenouille, N.; Bassil, C.F.; Lewis, C.A.; Ramos, A.; Gould, J.; Stone, R.M.; DeAngelo, D.J.; Galinsky, I.; Clish, C.B.; Kung, A.L.; Hemann, M.T.; Vander Heiden, M.G.; Banerji, V.; Stegmaier, K., 2017:
Targeting MTHFD2 in acute myeloid leukemia

Jonckheere, N.; Lahdaoui, F.; Van Seuningen, I., 2015:
Targeting MUC4 in pancreatic cancer: miRNAs

Castell, A.; Larsson, L-Gunnar., 2016:
Targeting MYC Translation in Colorectal Cancer

Koh, C.M.; Sabò, A.; Guccione, E., 2016:
Targeting MYC in cancer therapy: RNA processing offers new opportunities

Zinzalla, G., 2016:
Targeting MYC: is it getting any easier?

Zhang, H.; Liu, T.; Yi, S.; Gu, L.; Zhou, M., 2016:
Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation

Henssen, A.; Althoff, K.; Odersky, A.; Beckers, A.; Koche, R.; Speleman, F.; Schäfers, S.; Bell, E.; Nortmeyer, M.; Westermann, F.; De Preter, K.; Florin, A.; Heukamp, L.; Spruessel, A.; Astrahanseff, K.; Lindner, S.; Sadowski, N.; Schramm, A.; Astorgues-Xerri, L.; Riveiro, M.E.; Eggert, A.; Cvitkovic, E.; Schulte, J.H., 2018:
Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition

Chen, G.; Chang, J.; Zhang, D.; Pinho, S.; Jang, J-Eun.; Frenette, P.S., 2017:
Targeting Mac-1-mediated leukocyte-RBC interactions uncouples the benefits for acute vaso-occlusion and chronic organ damage

Anonymous, 2016:
Targeting Macrophages Boosts Pancreatic Cancer Therapy

Galletti, G.; Scielzo, C.; Barbaglio, F.; Rodriguez, T.Véliz.; Riba, M.; Lazarevic, D.; Cittaro, D.; Simonetti, G.; Ranghetti, P.; Scarfò, L.; Ponzoni, M.; Rocchi, M.; Corti, A.; Anselmo, A.; van Rooijen, N.; Klein, C.; Ries, C.H.; Ghia, P.; D.P.lma, M.; Caligaris-Cappio, F.; Bertilaccio, M.Teresa.Sabrina., 2016:
Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression

Peng, X.; Wang, J.; Li, X.; Lin, L.; Xie, G.; Cui, Z.; Li, J.; Wang, Y.; Li, L., 2015:
Targeting Mast Cells and Basophils with Anti-FcεRIα Fab-Conjugated Celastrol-Loaded Micelles Suppresses Allergic Inflammation

Cathcart, J.; Pulkoski-Gross, A.; Cao, J., 2015:
Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas

Lu, X.; Wang, J.; Jin, X.; Huang, Y.; Zeng, W.; Zhu, J., 2015 :
Targeting Mechanism of a Novel Liver-targeting Interferon IFN-CSP Involves Liver Heparan Sulfate Proteoglycan

van Mierlo, T.; Fournier, R.; Ingham, M., 2016:
Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development

Anonymous, 2016:
Targeting Mesothelin with Modified T Cells

Modena, A.; Massari, F.; Ciccarese, C.; Brunelli, M.; Santoni, M.; Montironi, R.; Martignoni, G.; Tortora, G., 2017:
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'?

Pisarsky, L.; Bill, R.; Fagiani, E.; Dimeloe, S.; Goosen, R.William.; Hagmann, Jörg.; Hess, C.; Christofori, G., 2016:
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

Cary, B.P.; Brooks, A.F.; Fawaz, M.V.; Shao, X.; Desmond, T.J.; Carpenter, G.M.; Sherman, P.; Quesada, C.A.; Albin, R.L.; Scott, P.J.H., 2015:
Targeting Metal-Aβ Aggregates with Bifunctional Radioligand [11C]L2-b and a Fluorine-18 Analogue [18F]FL2-b

Maltby, S.; Plank, M.; Tay, H.L.; Collison, A.; Foster, P.S., 2016:
Targeting MicroRNA Function in Respiratory Diseases: Mini-Review

Ozpinar, A.; Weiner, G.M.; Ducruet, A.F., 2016:
Targeting MicroRNA to Enhance Poststroke Recovery

Nattel, S., 2015:
Targeting MicroRNA-208a to Suppress Adverse Postmyocardial Infarction Remodelling Related to RNA Activation of Endoglin Gene Expression

You, H.Jeong.; Park, J.Hyon.; Pareja-Galeano, H.; Lucia, A.; Shin, J.Il., 2016:
Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases

Gupta, S.; Verma, S.; Mantri, S.; Berman, N.E.; Sandhir, R., 2016:
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders

Charafeddine, R.A.; Nosanchuk, J.D.; Sharp, D.J., 2016:
Targeting Microtubules for Wound Repair

Begum, R.; Martin, S.A., 2016:
Targeting Mismatch Repair defects: A novel strategy for personalized cancer treatment

Lindblom, R.; Higgins, G.; Coughlan, M.; de Haan, J.B., 2016:
Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy

Silva, F.S.G.; Simoes, R.F.; Couto, R.; Oliveira, P.J., 2016:
Targeting Mitochondria in Cardiovascular Diseases

Lee, E.A.; Angka, L.; Rota, S-Grace.; Hanlon, T.; Mitchell, A.; Hurren, R.; Wang, X.Ming.; Gronda, M.; Boyaci, E.; Bojko, B.; Minden, M.; Sriskanthadevan, S.; Datti, A.; Wrana, J.L.; Edginton, A.; Pawliszyn, J.; Joseph, J.W.; Quadrilatero, J.; Schimmer, A.D.; Spagnuolo, P.A., 2015:
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death

Aimo, A.; Borrelli, C.; Vergaro, G.; Piepoli, M.F.; Caterina, A.R.De.; Mirizzi, G.; Valleggi, A.; Raglianti, V.; Passino, C.; Emdin, M.; Giannoni, A., 2016:
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

Strifler, G.; Tuboly, E.; Görbe, Aó.; Boros, Mály.; Pécz, D.; Hartmann, P., 2016:
Targeting Mitochondrial Dysfunction with L-Alpha Glycerylphosphorylcholine

Zhang, X.; de Milito, A.; Olofsson, M.Hägg.; Gullbo, J.; D'Arcy, P.; Linder, S., 2016:
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors

Muchir, A.; Worman, H.J., 2016:
Targeting Mitogen-Activated Protein Kinase Signaling in Mouse Models of Cardiomyopathy Caused by Lamin A/C Gene Mutations

Fiore, M.; Forli, S.; Manetti, F., 2017:
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials

Dominguez-Brauer, C.; Thu, K.L.; Mason, J.M.; Blaser, H.; Bray, M.R.; Mak, T.W., 2016:
Targeting Mitosis in Cancer: Emerging Strategies

Heard, A.; Thompson, J.; Carver, J.; Bakey, M.; Wang, X.Robert., 2016:
Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?

Nigam, N.; Grover, A.; Goyal, S.; Katiyar, S.P.; Bhargava, P.; Wang, P-Chao.; Sundar, D.; Kaul, S.C.; Wadhwa, R., 2016:
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells

Randall, C.P.; Rasina, D.; Jirgensons, A.; O'Neill, A.J., 2017:
Targeting Multiple Aminoacyl-tRNA Synthetases Overcomes the Resistance Liabilities Associated with Antibacterial Inhibitors Acting on a Single Such Enzyme

Lackland, D.T., 2016:
Targeting Multivariable Risks: An Opportunity for Population High Blood Pressure Control

Anonymous, 2016:
Targeting Mutant AKT in Cancer

Tiacci, E.; Park, J.H.; D.C.rolis, L.; Chung, S.S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y.R.; Cimminiello, M.; Kim, E.; Rossi, D.; Stone, R.M.; Motta, G.; Saven, A.; Varettoni, M.; Altman, J.K.; Anastasia, A.; Grever, M.R.; Ambrosetti, A.; Rai, K.R.; Fraticelli, V.; Lacouture, M.E.; Carella, A.M.; Levine, R.L.; Leoni, P.; Rambaldi, A.; Falzetti, F.; Ascani, S.; Capponi, M.; Martelli, M.P.; Park, C.Y.; Pileri, S.A.; Rosen, N.; Foà, R.; Berger, M.F.; Zinzani, P.L.;, 2015:
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Sieniawska, E., 2016:
Targeting Mycobacterial Enzymes with Natural Products

Bockman, M.R.; Kalinda, A.S.; Petrelli, R.; De la Mora-Rey, T.; Tiwari, D.; Liu, F.; Dawadi, S.; Nandakumar, M.; Rhee, K.Y.; Schnappinger, D.; Finzel, B.C.; Aldrich, C.C., 2015:
Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors

Olsen, A.; Chen, Y.; Ji, Q.; Zhu, G.; De Silva, A.Dharshan.; Vilchèze, C.; Weisbrod, T.; Li, W.; Xu, J.; Larsen, M.; Zhang, J.; Porcelli, S.A.; Jacobs, W.R.; Chan, J., 2017:
Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines

Godbole, A.Anand.; Ahmed, W.; Bhat, R.Subray.; Bradley, E.K.; Ekins, S.; Nagaraja, V., 2015:
Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors

Liu, X.; Hunter, Z.R.; Xu, L.; Chen, J.; Chen, J.G.; Tsakmaklis, N.; Patterson, C.J.; Castillo, J.J.; Buhrlage, S.; Gray, N.; Treon, S.P.; Yang, G., 2016:
Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia

Hausenloy, D.J.; Yellon, D.M., 2015:
Targeting Myocardial Reperfusion Injury--The Search Continues

Stienen, S.; Salah, K.; Eurlings, L.W.; Bettencourt, P.; Pimenta, J.M.; Metra, M.; Bayes-Genis, A.; Verdiani, V.; Bettari, L.; Lazzarini, V.; Tijssen, J.P.; Pinto, Y.M.; Kok, W.E., 2018:
Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients

Wang, D.; Tang, J.; Tang, J.; Wang, L-Xi., 2015:
Targeting N-glycan cryptic sugar moieties for broad-spectrum virus neutralization: progress in identifying conserved molecular targets in viruses of distinct phylogenetic origins

Gorin, Y.; Cavaglieri, R.C.; Khazim, K.; Lee, D-Yoon.; Bruno, F.; Thakur, S.; Fanti, P.; Szyndralewiez, Cédric.; Barnes, J.L.; Block, K.; Abboud, H.E., 2015:
Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes

Pulla, V.K.; Sriram, D.S.; Soni, V.; Viswanadha, S.; Sriram, D.; Yogeeswari, P., 2016:
Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure-Based Drug Design and Biological Screening

Dubrac, A.; Genet, G.; Ola, R.; Zhang, F.; Pibouin-Fragner, L.; Han, J.; Zhang, J.; Thomas, J-Léon.; Chedotal, A.; Schwartz, M.A.; Eichmann, A., 2016:
Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization

Fang, Y.; Zhang, X., 2016:
Targeting NEK2 as a promising therapeutic approach for cancer treatment

Choi, B.Bora.; Kim, M.Soo.; Kim, U.Kyu.; Hong, J.Woo.; Lee, H.June.; Kim, G.Cheon., 2015:
Targeting NEU Protein in Melanoma Cells with Non-Thermal Atmospheric Pressure Plasma and Gold Nanoparticles

Bu, Y.; Cai, G.; Shen, Y.; Huang, C.; Zeng, X.; Cao, Y.; Cai, C.; Wang, Y.; Huang, D.; Liao, D-Fang.; Cao, D., 2016:
Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance

Friedmann-Morvinski, D.; Narasimamurthy, R.; Xia, Y.; Myskiw, C.; Soda, Y.; Verma, I.M., 2016:
Targeting NF-κB in glioblastoma: A therapeutic approach

Li, J.; Li, J.; Chen, R.; Cai, G., 2015:
Targeting NF-κΒ and TNF-α Activation by Electroacupuncture to Suppress Collagen-induced Rheumatoid Arthritis in Model Rats

Carotta, S., 2016:
Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches

Muñoz, M.; Coveñas, R., 2015:
Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach

Ben Aissa, M.; Lee, S.H.; Bennett, B.M.; Thatcher, G.R.J., 2016:
Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease

Herranz, D.; Ferrando, A.A., 2016:
Targeting NOTCH1 in T-ALL: Starving the dragon

Dasargyri, A.; Kümin, C.D.; Leroux, J-Christophe., 2016:
Targeting Nanocarriers with Anisamide: Fact or Artifact?

Pearce, A.K.; Fuchs, A.V.; Fletcher, N.L.; Thurecht, K.J., 2017:
Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo

Durlacher, C.T.; Chow, K.; Chen, X-Wu.; He, Z-Xu.; Zhang, X.; Yang, T.; Zhou, S-Feng., 2016:
Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment

Chen, B.; Le, W.; Wang, Y.; Li, Z.; Wang, D.; Ren, L.; Lin, L.; Cui, S.; Hu, J.J.; Hu, Y.; Yang, P.; Ewing, R.C.; Shi, D.; Cui, Z., 2017:
Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes

Al-Shabrawey, M.; Elsherbiny, M.; Nussbaum, J.; Othman, A.; Megyerdi, S.; Tawfik, A., 2013:
Targeting Neovascularization in Ischemic Retinopathy: Recent Advances

Skouras, V.S.; Maragkos, C.; Grapsa, D.; Syrigos, K.N., 2016:
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer

Sanvoranart, T.; Supokawej, A.; Kheolamai, P.; U-Pratya, Y.; Poungvarin, N.; Sathornsumetee, S.; Issaragrisil, S., 2016:
Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis

Rajasethupathy, P.; Ferenczi, E.; Deisseroth, K., 2016:
Targeting Neural Circuits

Dunlop, K.A.; Woodside, B.; Downar, J., 2016:
Targeting Neural Endophenotypes of Eating Disorders with Non-invasive Brain Stimulation

Kokaia, Z., 2016:
Targeting Neuroinflammation For Treatment Of Ischemic Stroke

Faingold, C.L.; Blumenfeld, H., 2016:
Targeting Neuronal Networks with Combined Drug and Stimulation Paradigms Guided by Neuroimaging to Treat Brain Disorders

Sercundes, M.K.; Ortolan, L.S.; Debone, D.; Soeiro-Pereira, P.V.; Gomes, E.; Aitken, E.H.; Condino-Neto, A.; Russo, M.; D' Império Lima, M.R.; Alvarez, Jé.M.; Portugal, S.; Marinho, C.R.F.; Epiphanio, S., 2017:
Targeting Neutrophils to Prevent Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome in Mice

Fan, H-Chuen.; Chi, C-Shiang.; Cheng, S-Nan.; Lee, H-Fen.; Tsai, J-Dau.; Lin, S-Zong.; Harn, H-Jyh., 2016:
Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases

Sallustio, F.; Studer, V., 2017:
Targeting New Pharmacological Approaches for Alzheimer's Disease: Potential for Statins and Phosphodiesterase Inhibitors

Wang, S-Na.; Xu, T-Ying.; Li, W-Lin.; Miao, C-Yu., 2016:
Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis

Forte, M.; Conti, V.; Damato, A.; Ambrosio, M.; Puca, A.A.; Sciarretta, S.; Frati, G.; Vecchione, C.; Carrizzo, A., 2016:
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases

Hallenbeck, K.K.; Turner, D.M.; Renslo, A.R.; Arkin, M.R., 2016:
Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery

Basak, J.; Nithin, C., 2015:
Targeting Non-Coding RNAs in Plants with the CRISPR-Cas Technology is a Challenge yet Worth Accepting

Yang, Y.; Kelly, P.; Shaffer, A.L.; Schmitz, R.; Yoo, H.Min.; Liu, X.; Huang, D.Wei.; Webster, D.; Young, R.M.; Nakagawa, M.; Ceribelli, M.; Wright, G.W.; Yang, Y.; Zhao, H.; Yu, X.; Xu, W.; Chan, W.C.; Jaffe, E.S.; Gascoyne, R.D.; Campo, E.; Rosenwald, A.; Ott, G.; Delabie, J.; Rimsza, L.; Staudt, L.M., 2016:
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma

Nagel-Wolfrum, K.; Möller, F.; Penner, I.; Baasov, T.; Wolfrum, U., 2016:
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)

Wilson, M.R.; Hou, Z.; Yang, S.; Polin, L.; Kushner, J.; White, K.; Huang, J.; Ratnam, M.; Gangjee, A.; Matherly, L.H., 2016:
Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates

Natsumeda, M.; Maitani, K.; Liu, Y.; Miyahara, H.; Kaur, H.; Chu, Q.; Zhang, H.; Kahlert, U.D.; Eberhart, C.G., 2015:
Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres

Platonova, N.; Lesma, E.; Basile, A.; Bignotto, M.; Garavelli, S.; Palano, M.Teresa.; Moschini, A.; Neri, A.; Colombo, M.; Chiaramonte, R., 2016:
Targeting Notch as a Therapeutic Approach for Human Malignancies

Liu, J.; Shen, J-Xin.; Wen, X-Fen.; Guo, Y-Xian.; Zhang, G-Jun., 2016:
Targeting Notch degradation system provides promise for breast cancer therapeutics

Krepler, C.; Xiao, M.; Samanta, M.; Vultur, A.; Chen, H-Yi.; Brafford, P.; Reyes-Uribe, P.I.; Halloran, M.; Chen, T.; He, X.; Hristova, D.; Liu, Q.; Samatar, A.A.; Davies, M.A.; Nathanson, K.L.; Fukunaga-Kalabis, M.; Herlyn, M.; Villanueva, J., 2016:
Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma

Asnaghi, L.; Tripathy, A.; Yang, Q.; Kaur, H.; Hanaford, A.; Yu, W.; Eberhart, C.G., 2016:
Targeting Notch signaling as a novel therapy for retinoblastoma

Lee, H-Woo.; Kim, S-Jun.; Choi, I.Ju.; Song, J.; Chun, K-Hee., 2015:
Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer

Yen, W-Ching.; Fischer, M.M.; Axelrod, F.; Bond, C.; Cain, J.; Cancilla, B.; Henner, W.R.; Meisner, R.; Sato, A.; Shah, J.; Tang, T.; Wallace, B.; Wang, M.; Zhang, C.; Kapoun, A.M.; Lewicki, J.; Gurney, A.; Hoey, T., 2016:
Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency

Yahyanejad, S.; Theys, J.; Vooijs, M., 2015:
Targeting Notch to overcome radiation resistance

Ono, M.; Takimoto, R.; Osuga, T.; Okagawa, Y.; Hirakawa, M.; Yoshida, M.; Arihara, Y.; Uemura, N.; Hayasaka, N.; Miura, S.; Matsuno, T.; Tamura, F.; Sato, Y.; Sato, T.; Iyama, S.; Miyanishi, K.; Takada, K.; Kobune, M.; Kato, J., 2016:
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin

Yang, L.; Zhang, S.; George, S.Konnath.; Teng, R.; You, X.; Xu, M.; Liu, H.; Sun, X.; Amin, H.M.; Shi, W., 2016 :
Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

Liu, Y.; Su, C.; Shan, Y.; Yang, S.; Ma, G., 2016:
Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-κB signaling

van der Wijst, M.G.P.; Huisman, C.; Mposhi, A.; Roelfes, G.; Rots, M.G., 2016:
Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion

Kim, E.Hye.; Jang, H.; Shin, D.; Baek, S.Ho.; Roh, J-Lyel., 2016:
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer

Anonymous, 2016:
Targeting Nuclear Envelope Repair

Choi, Y.; Oh, S.Taek.; Won, M-Ah.; Choi, K.Mi.; Ko, M.Ji.; Seo, D.; Jeon, T-Won.; Baik, I.Hye.; Ye, S-Kyu.; Park, K.Uk.; Park, I-Chul.; Jang, B-Churl.; Seo, J-Young.; Lee, Y-Han., 2017:
Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma

Gallo, A.; Perrone, G., 2018:
Targeting Ochratoxin Biosynthetic Genes

Egal, M.; Erler, N.S.; de Geus, H.R.H.; van Bommel, J.; Groeneveld, A.B.Johan., 2016:
Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients: A Systematic Review and Meta-Analysis

Holloway, K.R.; Sinha, V.C.; Bu, W.; Toneff, M.; Dong, J.; Peng, Y.; Li, Y., 2016:
Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype

Parrales, A.; Iwakuma, T., 2016 :
Targeting Oncogenic Mutant p53 for Cancer Therapy

Ser, Z.; Gao, X.; Johnson, C.; Mehrmohamadi, M.; Liu, X.; Li, S.; Locasale, J.W., 2017:
Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow

Arout, C.A.; Edens, E.; Petrakis, I.L.; Sofuoglu, M., 2016:
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

Anonymous, 2016:
Targeting Oral Cancer

Ye, C.; Geng, Z.; Dominguez, D.; Chen, S.; Fan, J.; Qin, L.; Long, A.; Zhang, Y.; Kuzel, T.M.; Zhang, B., 2016:
Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells

Andrade, Mía.J.; Rodríguez, M.; Córdoba, J.J.; Rodríguez, A., 2018:
Targeting Other Mycotoxin Biosynthetic Genes

Do, K.Q.; Cuenod, M.; Hensch, T.K., 2016:
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia

Patel, M., 2017:
Targeting Oxidative Stress in Central Nervous System Disorders

Abuelezz, S.A.; Hendawy, N.; Magdy, Y., 2016:
Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats

Kuan, Y-Hui.; Shih, H-Chien.; Tang, S-Chun.; Jeng, J-Shing.; Shyu, B-Chuang., 2016:
Targeting P(2)X(7) receptor for the treatment of central post-stroke pain in a rodent model

Xue, C.; Wang, C.; Liu, Q.; Meng, Q.; Sun, H.; Huo, X.; Ma, X.; Liu, Z.; Ma, X.; Peng, J.; Liu, K., 2016:
Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin

Yang, Z-Hui.; Wu, B-Lei.; Ye, C.; Jia, S.; Yang, X-Jie.; Hou, R.; Lei, D-Lin.; Wang, L., 2016:
Targeting P38 Pathway Regulates Bony Formation ivia MSC Recruitment during Mandibular Distraction Osteogenesis in Rats

Tanday, S., 2016:
Targeting PADI2 could stop the progression of myeloma

Palmbos, P.L.; Hussain, M.H., 2016:
Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and Promise

Joel, M.; Mughal, A.A.; Grieg, Z.; Murrell, W.; Palmero, S.; Mikkelsen, B.; Fjerdingstad, H.B.; Sandberg, C.J.; Behnan, J.; Glover, J.C.; Langmoen, I.A.; Stangeland, B., 2016:
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo

Wang, W.; Liu, W.Bin.; Huang, D.Bing.; Jia, W.; Ji, C.Shu.; Hu, B., 2016:
Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma

Della Badia, L.A.; Elshourbagy, N.A.; Mousa, S.A., 2017:
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol

Shapiro, M.D.; Fazio, S.; Tavori, H., 2015:
Targeting PCSK9 for therapeutic gains

Banerjee, Y.; Santos, R.D.; Al-Rasadi, K.; Rizzo, M., 2016:
Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?

Liu, J.; Zhang, S.; Hu, Y.; Yang, Z.; Li, J.; Liu, X.; Deng, L.; Wang, Y.; Zhang, X.; Jiang, T.; Lu, X., 2016:
Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines

Weinstock, M.; McDermott, D., 2015:
Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma

Feld, E.; Horn, L., 2016:
Targeting PD-L1 for non-small-cell lung cancer

Qin, L.; Tian, Y.; Yu, Z.; Shi, D.; Wang, J.; Zhang, C.; Peng, R.; Chen, X.; Liu, C.; Chen, Y.; Huang, W.; Deng, W., 2016:
Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth

Fortin, Jérôme.; Mak, T.W., 2016:
Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs

Okkenhaug, K.; Graupera, M.; Vanhaesebroeck, B., 2016:
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy

Crosswell, H.E.; Peng, Q.; Prince, C.; De, P.; Durden, D.L., 2016:
Targeting PI3K in alveolar rhabdomyosarcoma (aRMS)

Hsu, A.Chen-Yu.; Starkey, M.R.; Hanish, I.; Parsons, K.; Haw, T.Jhong.; Howland, L.J.; Barr, I.; Mahony, J.B.; Foster, P.S.; Knight, D.A.; Wark, P.A.; Hansbro, P.M., 2015:
Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease

Bertacchini, J.; Heidari, N.; Mediani, L.; Capitani, S.; Shahjahani, M.; Ahmadzadeh, A.; Saki, N., 2015:
Targeting PI3K/AKT/mTOR network for treatment of leukemia

Chang, L.; Graham, P.H.; Ni, J.; Hao, J.; Bucci, J.; Cozzi, P.J.; Li, Y., 2015:
Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Lee, M.; Wiedemann, T.; Gross, C.; Leinhäuser, I.; Roncaroli, F.; Braren, R.; Pellegata, N.S., 2016:
Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas

Lee, M.; Minaskan, N.; Wiedemann, T.; Irmler, M.; Beckers, J.; Yousefi, B.H.; Kaissis, G.; Braren, R.; Laitinen, I.; Pellegata, N.S., 2016:
Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo

Pillinger, G.; Loughran, N.V.; Piddock, R.E.; Shafat, M.S.; Zaitseva, L.; Abdul-Aziz, A.; Lawes, M.J.; Bowles, K.M.; Rushworth, S.A., 2016:
Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection

Wei, M.; Wang, X.; Song, Z.; Jiao, M.; Ding, J.; Meng, L-Hua.; Zhang, A., 2016:
Targeting PI3Kδ: emerging therapy for chronic lymphocytic leukemia and beyond

Jain, K.; Ajay, D.; Sobhia, M.Elizabeth., 2011:
Targeting PKC-β II and PKB Connection: Design of Dual Inhibitors

Jain, K.; Sobhia, M.Elizabeth., 2011:
Targeting PKC-β II by Peptides and Peptidomimetics Derived from RACK 1: An In Silico Approach

Ohama, T., 2015:
Targeting PP2A inhibitors as a novel anti-cancer strategy


Cristóbal, I.; Torrejón, B.; Pedregal, M.; Rojo, F.; García-Foncillas, Jús., 2016:
Targeting PP2A to overcome enzalutamide resistance in AR+ breast tumors

Chong, Z.Zhong., 2016:
Targeting PRAS40 for multiple diseases

He, D-Xu.; Gu, F.; Wu, J.; Gu, X-Ting.; Lu, C-Xiao.; Mao, A-Qin.; Zhang, G-Yuan.; Ding, Z-Yang.; Wang, J-Ke.; Hao, J-Jun.; Fu, L.; Ma, X., 2016:
Targeting PSG1 to enhance chemotherapeutic efficacy: new application for anti-coagulant the dicumarol

Nedrow, J.R.; Latoche, J.D.; Day, K.E.; Modi, J.; Ganguly, T.; Zeng, D.; Kurland, B.F.; Berkman, C.E.; Anderson, C.J., 2017:
Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer

Mak, L.Hang.; Woscholski, R., 2016:
Targeting PTEN using small molecule inhibitors

Maggi, L.B.; Weber, J.D., 2015:
Targeting PTEN-defined breast cancers with a one-two punch

Razidlo, G.L.; Magnine, C.; Sletten, A.C.; Hurley, R.M.; Almada, L.L.; Fernandez-Zapico, M.E.; Ji, B.; McNiven, M.A., 2015:
Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion

Curtis, K.Elizabeth.; Lahiri, S.; Brown, K.Elizabeth., 2015:
Targeting Parents for Childhood Weight Management: Development of a Theory-Driven and User-Centered Healthy Eating App

Licciardone, J.C.; Gatchel, R.J.; Aryal, S., 2016:
Targeting Patient Subgroups With Chronic Low Back Pain for Osteopathic Manipulative Treatment: Responder Analyses From a Randomized Controlled Trial

Peters, J.M.; Yao, P-Li.; Gonzalez, F.J., 2015:
Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention

Pleasants, R.A.; Heidari, K.; Wheaton, A.G.; Ohar, J.A.; Strange, C.; Croft, J.B.; Liao, W.; Mannino, D.M.; Kraft, M., 2016:
Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance

Kwon, J.; Kim, D.Hyo.; Park, J.Min.; Park, Y.Hee.; Hwang, Y.Hyun.; Wu, H-Gyun.; Shin, K.Hwan.; Kim, I.Ah., 2016:
Targeting Phosphatidylinositol 4-Kinase IIIα for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral Agent

Perreault, A.; Richter, S.; Bergman, C.; Wuest, M.; Wuest, F., 2016:
Targeting Phosphatidylserine with a 64Cu-Labeled Peptide for Molecular Imaging of Apoptosis

Le, B.Thuy.; Kumarasiri, M.; Adams, J.R.J.; Yu, M.; Milne, R.; Sykes, M.J.; Wang, S., 2015:
Targeting Pim kinases for cancer treatment: opportunities and challenges

Wang, Y.; Li, Z.; Zhang, Y.; Yang, W.; Sun, J.; Shan, L.; Li, W., 2016:
Targeting Pin1 Protects Mouse Cardiomyocytes from High-Dose Alcohol-Induced Apoptosis

Williams, J.A.; Ding, W-Xing., 2016:
Targeting Pink1-Parkin-mediated mitophagy for treating liver injury

Bisson, M.M.A.; Groth, G., 2016:
Targeting Plant Ethylene Responses by Controlling Essential Protein-Protein Interactions in the Ethylene Pathway

Avitia-Domínguez, C.; Sierra-Campos, E.; Betancourt-Conde, I.; Aguirre-Raudry, M.; Vázquez-Raygoza, A.; Luevano-De la Cruz, A.; Favela-Candia, A.; Sarabia-Sanchez, M.; Ríos-Soto, L.; Méndez-Hernández, E.; Cisneros-Martínez, J.; Palacio-Gastélum, M.Gómez.; Valdez-Solana, Mónica.; Hernández-Rivera, J.; De Lira-Sánchez, J.; Campos-Almazán, M.; Téllez-Valencia, A., 2016:
Targeting Plasmodium Metabolism to Improve Antimalarial Drug Design

Strittmatter, K.; Pomeroy, H.; Marneros, A.G., 2017 :
Targeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal Neovascularization

Liu, X., 2015:
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment

Arnsten, A.F.T.; Wang, M., 2016:
Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders

Coric, V.; Salloway, S.; van Dyck, C.H.; Dubois, B.; Andreasen, N.; Brody, M.; Curtis, C.; Soininen, H.; Thein, S.; Shiovitz, T.; Pilcher, G.; Ferris, S.; Colby, S.; Kerselaers, W.; Dockens, R.; Soares, H.; Kaplita, S.; Luo, F.; Pachai, C.; Bracoud, L.; Mintun, M.; Grill, J.D.; Marek, K.; Seibyl, J.; Cedarbaum, J.M.; Albright, C.; Feldman, H.H.; Berman, R.M., 2016:
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

Homicsko, K.; Coukos, G., 2016:
Targeting Programmed Cell Death 1 in Ovarian Cancer

Ke, B.; Tian, M.; Li, J.; Liu, B.; He, G., 2016:
Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy

Younes, A., 2016:
Targeting Programmed Death 1/Programmed Death Ligand 1 in Lymphoma: A Game Changer

O'Sullivan, C.C.; Bates, S.E., 2016:
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer

Dowling, Cíona.M.; Kiely, P.A., 2015:
Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling

Goodman, C.D.; Pasaje, C.Flerida.A.; Kennedy, K.; McFadden, G.I.; Ralph, S.A., 2016:
Targeting Protein Translation in Organelles of the Apicomplexa

Wilkins, S.E.; Abboud, M.I.; Hancock, R.L.; Schofield, C.J., 2016:
Targeting Protein-Protein Interactions in the HIF System

Gaczynska, M.; Osmulski, P.A., 2016:
Targeting Protein-Protein Interactions in the Proteasome Super-Assemblies

Mims, J.W., 2016:
Targeting Quality Improvement in Clinical Practice Guidelines

Cox, A.D.; Der, C.J.; Philips, M.R., 2016:
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Bates, S.E., 2016:
Targeting RAS: The Elusive Prize

Bullock, A.N.; Degterev, A., 2016:
Targeting RIPK1,2,3 to combat inflammation

Jung, E-Hwa.; Lee, H-Na.; Han, G-Yeon.; Kim, M-Jung.; Kim, C-Wha., 2016:
Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells

Fatkhutdinov, N.; Sproesser, K.; Krepler, C.; Liu, Q.; Brafford, P.A.; Herlyn, M.; Aird, K.M.; Zhang, R., 2017:
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma

Regad, T., 2015:
Targeting RTK Signaling Pathways in Cancer

Chang, L.; Huang, J.; Wang, K.; Li, J.; Yan, R.; Zhu, L.; Ye, J.; Wu, X.; Zhuang, S.; Li, D.; Zhang, G., 2016:
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy

Visweswaran, G.Ram.R.; Gholizadeh, S.; Ruiters, M.H.J.; Molema, G.; Kok, R.J.; Kamps, J.A.A.M., 2016:
Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System

Koseoglu, M.Murat.; Ozdilek, B.Akdogan.; Djakbarova, U.; Gulusur, A., 2016:
Targeting Ras Activity Prevented Amyloid Beta-Induced Aberrant Neuronal Cell Cycle Re-Entry and Death

Hwang, S.Won.; Lee, Y-Mi.; Aldini, G.; Yeum, K-Jin., 2016:
Targeting Reactive Carbonyl Species with Natural Sequestering Agents

Maxson, T.; Tietz, J.I.; Hudson, G.A.; Guo, X.Rui.; Tai, H-Chia.; Mitchell, D.A., 2016:
Targeting Reactive Carbonyls for Identifying Natural Products and Their Biosynthetic Origins

Shabani, M.; Hojjat-Farsangi, M., 2015:
Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

Freeman, D.; Bradley, J.; Waite, F.; Sheaves, B.; DeWeever, N.; Bourke, E.; McInerney, J.; Evans, N.; Černis, E.; Lister, R.; Garety, P.; Dunn, G., 2016:
Targeting Recovery in Persistent Persecutory Delusions: A Proof of Principle Study of a New Translational Psychological Treatment (the Feeling Safe Programme)

Rooper, L.; Carter, J.; Hargrove, J.; Hoffmann, S.; Riedel, S., 2016:
Targeting Rejection: Analysis of Specimen Acceptability and Rejection, and Framework for Identifying Interventions in a Single Tertiary Healthcare Facility

Tan, J., 2016:
Targeting Resistance

Lerner, V.; McCaffery, P.J.A.; Ritsner, M.S., 2016:
Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date

Shah, K.N.; Wilson, E.A.; Malla, R.; Elford, H.L.; Faridi, J.S., 2016:
Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer

Jacobs, R.H.; Watkins, E.R.; Peters, A.T.; Feldhaus, C.G.; Barba, A.; Carbray, J.; Langenecker, S.A., 2016:
Targeting Ruminative Thinking in Adolescents at Risk for Depressive Relapse: Rumination-Focused Cognitive Behavior Therapy in a Pilot Randomized Controlled Trial with Resting State fMRI

Bamias, G.; Rivera-Nieves, J., 2016:
Targeting S1P Receptors, A New Mechanism of Action for Inflammatory Bowel Disease Therapy

Yong, K.Jia.; Li, A.; Ou, W-Bin.; Hong, C.Kit.Yee.; Zhao, W.; Wang, F.; Tatetsu, H.; Yan, B.; Qi, L.; Fletcher, J.A.; Yang, H.; Soo, R.; Tenen, D.G.; Chai, L., 2016:
Targeting SALL4 by entinostat in lung cancer

Bouyssou, J.M.C.; Ghobrial, I.M.; Roccaro, A.M., 2015:
Targeting SDF-1 in multiple myeloma tumor microenvironment

Morlacchi, P.; Robertson, F.M.; Klostergaard, J.; McMurray, J.S., 2015:
Targeting SH2 domains in breast cancer

Hassanein, M.; Qian, J.; Hoeksema, M.D.; Wang, J.; Jacobovitz, M.; Ji, X.; Harris, F.T.; Harris, B.K.; Boyd, K.L.; Chen, H.; Eisenberg, R.; Massion, P.P., 2015:
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer

Wei, C-Rong.; Liu, J.; Yu, X-Jun., 2016:
Targeting SLUG sensitizes leukemia cells to ADR-induced apoptosis

Danese, S.; Fiorino, G.; Peyrin-Biroulet, L., 2015:
Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?

Sajesh, B.V.; McManus, K.J., 2016:
Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells

Garros-Regulez, L.; Garcia, I.; Carrasco-Garcia, E.; Lantero, A.; Aldaz, P.; Moreno-Cugnon, L.; Arrizabalaga, O.; Undabeitia, J.; Torres-Bayona, S.; Villanua, J.; Ruiz, I.; Egaña, L.; Sampron, N.; Matheu, A., 2016:
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma

Zheng, T.; Yang, C-Guang., 2016:
Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy

Wee, C.D.; Havens, M.A.; Jodelka, F.M.; Hastings, M.L., 2016:
Targeting SR proteins improves SMN expression in spinal muscular atrophy cells

Rajora, M.A.; Zheng, G., 2016:
Targeting SR-BI for Cancer Diagnostics, Imaging and Therapy

Soyal, S.M.; Nofziger, C.; Dossena, S.; Paulmichl, M.; Patsch, W., 2016:
Targeting SREBPs for treatment of the metabolic syndrome

Meng, C.; Guo, L-Bin.; Liu, X.; Chang, Y-Hsin.; Lin, Y., 2016:
Targeting STAT1 in Both Cancer and Insulin Resistance Diseases

Bu, L-Lin.; Yu, G-Tao.; Deng, W-Wei.; Mao, L.; Liu, J-Feng.; Ma, S-Rui.; Fan, T-Fei.; Hall, B.; Kulkarni, A.B.; Zhang, W-Feng.; Sun, Z-Jun., 2016:
Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma

Sun, S-Shan.; Zhou, X.; Huang, Y-Yuan.; Kong, L-Ping.; Mei, M.; Guo, W-Yu.; Zhao, M-Hui.; Ren, Y.; Shen, Q.; Zhang, L., 2016:
Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma

Gravekamp, C.; Chandra, D., 2015:
Targeting STING pathways for the treatment of cancer

Vaiman, D.; Miralles, F., 2016:
Targeting STOX1 in the therapy of preeclampsia

Marcelli, S.; Ficulle, E.; Iannuzzi, F.; Kövari, Eö.; Nisticò, R.; Feligioni, M., 2016:
Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease

Huang, P.H., 2016:
Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy

Guan, J.; Hawryluk, G.W.J., 2016:
Targeting Secondary Hematoma Expansion in Spontaneous Intracerebral Hemorrhage - State of the Art

Mooradian, A.D., 2016:
Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm

Natoni, A.; Macauley, M.S.; O'Dwyer, M.E., 2016:
Targeting Selectins and Their Ligands in Cancer

Velarde, M.C.; Demaria, M., 2018:
Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-Review

Roy, A.; Femel, J.; Huijbers, E.J.M.; Spillmann, D.; Larsson, E.; Ringvall, M.; Olsson, A-Karin.; Åbrink, M., 2017:
Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma

Spence, S.; Greene, M.K.; Fay, Fçois.; Hams, E.; Saunders, S.P.; Hamid, U.; Fitzgerald, M.; Beck, J.; Bains, B.K.; Smyth, P.; Themistou, E.; Small, D.M.; Schmid, D.; O'Kane, C.M.; Fitzgerald, D.C.; Abdelghany, S.M.; Johnston, J.A.; Fallon, P.G.; Burrows, J.F.; McAuley, D.F.; Kissenpfennig, A.; Scott, C.J., 2016:
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation

Muggen, A.F.; Singh, S.P.; Hendriks, R.W.; Langerak, A.W., 2016:
Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Abbosh, P.H.; McConkey, D.J.; Plimack, E.R., 2016:
Targeting Signaling Transduction Pathways in Bladder Cancer

Blagotinsek, K.; Rozman, D., 2016:
Targeting Signalling Pathways in Hepatocellular Carcinoma

Mallory, L.A.; Calaman, S.; Lee White, M.; Doughty, C.; Mangold, K.; Lopreiato, J.; Auerbach, M.; Chang, T.P., 2015:
Targeting Simulation-Based Assessment for the Pediatric Milestones: A Survey of Simulation Experts and Program Directors

Chang, A.; Bossé, Y., 2016:
Targeting Single Molecules in Asthma Benefits Few

Levine, M.H.; Wang, Z.; Xiao, H.; Jiao, J.; Wang, L.; Bhatti, T.R.; Hancock, W.W.; Beier, U.H., 2016:
Targeting Sirtuin-1 prolongs murine renal allograft survival and function

Brierley, C.K.; Steensma, D.P., 2016:
Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms

Homsi, J.; Messina, J.; Cubutt, C.; Maunglay, S.; Scalf, L.; Komarla, A.; Yu, H.; Jove, R.; Daud, A., 2016:
Targeting Src/Stat3 pathway in malignant melanoma

Narayan, S.M.; Krummen, D.E., 2012:
Targeting Stable Rotors to Treat Atrial Fibrillation

Kong, C.; Neoh, H-min.; Nathan, S., 2016:
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy

Egan, J.M., 2015:
Targeting Stem Cells in Chronic Myeloid Leukemia with a PPAR-γ Agonist

Sarkar, M.; Liu, Y.; Qi, J.; Peng, H.; Morimoto, J.; Rader, C.; Chiorazzi, N.; Kodadek, T., 2016:
Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates

Gobbi, S.; Hu, Q.; Zimmer, C.; Belluti, F.; Rampa, A.; Hartmann, R.W.; Bisi, A., 2017:
Targeting Steroidogenic Cytochromes P450 (CYPs) with 6-Substituted 1-Imidazolylmethylxanthones

Moccia, F.; Zuccolo, E.; Poletto, V.; Turin, I.; Guerra, G.; Pedrazzoli, P.; Rosti, V.; Porta, C.; Montagna, D., 2016:
Targeting Stim and Orai Proteins as an Alternative Approach in Anticancer Therapy

Yuan, Z-Xiang.; Mo, J.; Zhao, G.; Shu, G.; Fu, H-Lin.; Zhao, W., 2016:
Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells

Yang, L.; Achreja, A.; Yeung, T-Lun.; Mangala, L.S.; Jiang, D.; Han, C.; Baddour, J.; Marini, J.C.; Ni, J.; Nakahara, R.; Wahlig, S.; Chiba, L.; Kim, S.Hye.; Morse, J.; Pradeep, S.; Nagaraja, A.Sidalaghatta.; Haemmerle, M.; Kyunghee, N.; Derichsweiler, M.; Plackemeier, T.; Mercado-Uribe, I.; Lopez-Berestein, G.; Moss, T.; Ram, P.T.; Liu, J.; Lu, X.; Mok, S.C.; Sood, A.K.; Nagrath, D., 2017:
Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth

Yeung, T-Lun.; Leung, C.S.; Li, F.; Wong, S.S.T.; Mok, S.C., 2016:
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment

Willard, N.; Chutuape, K.; Stewart-Campbell, R.; Boyer, C.B.; Ellen, J., 2016:
Targeting Structural Change for HIV Prevention: A Process and Tool for Community Application

Mao, Y.; Eissler, N.; Blanc, K.Le.; Johnsen, J.Inge.; Kogner, P.; Kiessling, R., 2018:
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

Mutonga, M.; Tamura, K.; Malnassy, G.; Fulton, N.; de Albuquerque, A.; Hamamoto, R.; Stock, W.; Nakamura, Y.; Alachkar, H., 2015:
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)

Ferrario, A.; Luna, M.; Rucker, N.; Wong, S.; Lederman, A.; Kim, J.; Gomer, C., 2016:
Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors

Carew, J.S.; Espitia, C.M.; Zhao, W.; Mita, M.M.; Mita, A.C.; Nawrocki, S.T., 2016:
Targeting Survivin Inhibits Renal Cell Carcinoma Progression and Enhances the Activity of Temsirolimus

Du, J.; Ge, X.; Liu, Y.; Jiang, P.; Wang, Z.; Zhang, R.; Zhou, L.; Guo, X.; Han, J.; Yang, H., 2016:
Targeting Swine Leukocyte Antigen Class I Molecules for Proteasomal Degradation by the nsp1α Replicase Protein of the Chinese Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Strain JXwn06

Deng, G-Min.; Kyttaris, V.C.; Tsokos, G.C., 2016:
Targeting Syk in Autoimmune Rheumatic Diseases

Flynn, R.; Allen, J.L.; Luznik, L.; MacDonald, K.P.; Paz, K.; Alexander, K.A.; Vulic, A.; Du, J.; Panoskaltsis-Mortari, A.; Taylor, P.A.; Poe, J.C.; Serody, J.S.; Murphy, W.J.; Hill, G.R.; Maillard, I.; Koreth, J.; Cutler, C.S.; Soiffer, R.J.; Antin, J.H.; Ritz, J.; Chao, N.J.; Clynes, R.A.; Sarantopoulos, S.; Blazar, B.R., 2015:
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease

Orecchia, P.; Conte, R.; Balza, E.; Pietra, G.; Mingari, M.Cristina.; Carnemolla, B., 2016:
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts

McIver, Z.A.; Grayson, J.M.; Coe, B.N.; Hill, J.E.; Schamerhorn, G.A.; Ohulchanskyy, T.Y.; Linder, M.K.; Davies, K.S.; Weiner, R.S.; Detty, M.R., 2017:
Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease

Callahan, M.K.; Postow, M.A.; Wolchok, J.D., 2016:
Targeting T Cell Co-receptors for Cancer Therapy

O'Sullivan, D.; Pearce, E.L., 2015:
Targeting T cell metabolism for therapy

Bullenkamp, J.; Dinkla, S.; Kaski, J.Carlos.; Dumitriu, I.E., 2016:
Targeting T cells to treat atherosclerosis: odyssey from bench to bedside

Kim, S-Mi.; Lee, S-Ho.; Lee, A.; Kim, D-Jin.; Kim, Y-Gyun.; Kim, S-Yun.; Jeong, K-Hwan.; Lee, T-Won.; Ihm, C-Gyoo.; Lim, S-Jig.; Moon, J-Young., 2015:
Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression

Gong, M.; Yang, H.; Zhang, S.; Yang, Y.; Zhang, D.; Li, Z.; Zou, L., 2016:
Targeting T1 and T2 dual modality enhanced magnetic resonance imaging of tumor vascular endothelial cells based on peptides-conjugated manganese ferrite nanomicelles

Alquezar, C.; Salado, I.G.; de la Encarnación, A.; Pérez, D.I.; Moreno, Fín.; Gil, C.; de Munain, A.López.; Martínez, A.; Martín-Requero, Ángeles., 2017:
Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia

Mao, Y.; Chen, X.; Xu, M.; Fujita, K.; Motoki, K.; Sasabe, T.; Homma, H.; Murata, M.; Tagawa, K.; Tamura, T.; Kaye, J.; Finkbeiner, S.; Blandino, G.; Sudol, M.; Okazawa, H., 2016:
Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology

Peterson, J.A.; Maroney, S.A.; Mast, A.E., 2016:
Targeting TFPI for hemophilia treatment

Li, Y.; Chen, D.; Hao, F-Y.; Zhang, K-J., 2017:
Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo

Zhang, K.; Liu, X.; Hao, F.; Dong, A.; Chen, D., 2016:
Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling

Rodrigues, Cília.M.P.; Moshage, H., 2016:
Targeting TGR5 in cholangiocyte proliferation: default topic

Ghochikyan, A.; Pichugin, A.; Bagaev, A.; Davtyan, A.; Hovakimyan, A.; Tukhvatulin, A.; Davtyan, H.; Shcheblyakov, D.; Logunov, D.; Chulkina, M.; Savilova, A.; Trofimov, D.; Nelson, E.L.; Agadjanyan, M.G.; Ataullakhanov, R.I., 2016:
Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

Bertrand, F.; Rochotte, J.; Colacios, Céline.; Montfort, A.; Andrieu-Abadie, N.; Levade, T.; Benoist, Hé.; Ségui, B., 2016:
Targeting TNF alpha as a novel strategy to enhance CD8 + T cell-dependent immune response in melanoma?

Kumar, A.; Coquard, L.; Herbein, G., 2016:
Targeting TNF-Alpha in HIV-1 Infection

Dai, X.; Zhang, J.; Arfuso, F.; Chinnathambi, A.; Zayed, M.E.; Alharbi, S.Ali.; Kumar, A.Prem.; Ahn, K.Seok.; Sethi, G., 2015:
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy

Ding, X.; Yang, D-Rong.; Xia, L.; Chen, B.; Yu, S.; Niu, Y.; Wang, M.; Li, G.; Chang, C., 2016:
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals

Moore, C.R.; Edwards, S.Ke.; Xie, P., 2015:
Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms

Hu, J.; Zhu, X-Hai.; Zhang, X-Jing.; Wang, P-Xiao.; Zhang, R.; Zhang, P.; Zhao, G-Nian.; Gao, L.; Zhang, X-Fei.; Tian, S.; Li, H., 2016:
Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury

Lim, B.; Allen, J.E.; Prabhu, V.V.; Talekar, M.K.; Finnberg, N.K.; El-Deiry, W.S., 2016:
Targeting TRAIL in the treatment of cancer: new developments

Condelli, V.; Maddalena, F.; Sisinni, L.; Lettini, G.; Matassa, D.Swann.; Piscazzi, A.; Palladino, G.; Amoroso, M.Rosaria.; Esposito, F.; Landriscina, M., 2016:
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma

Yang, C.; Zhao, J.; Lin, L.; Pan, S.; Fu, L.; Han, L.; Jin, M.; Zhou, R.; Zhang, A., 2016:
Targeting TREM-1 Signaling in the Presence of Antibiotics is Effective Against Streptococcal Toxic-Shock-Like Syndrome (STSLS) Caused by Streptococcus suis

Bonvini, S.J.; Birrell, M.A.; Smith, J.A.; Belvisi, M.G., 2016:
Targeting TRP channels for chronic cough: from bench to bedside

Gomtsyan, A.; Szallasi, A., 2016:
Targeting TRP channels: beyond TRPV1

Klumpp, D.; Misovic, M.; Szteyn, K.; Shumilina, E.; Rudner, J.; Huber, S.M., 2016:
Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells in a Bcl-2-Dependent Manner

Yamamoto, S.; Shimizu, S., 2016:
Targeting TRPM2 in ROS-Coupled Diseases

Veale, T.K., 1999:
Targeting Temporal Processing Deficits Through Fast ForWord®: Language Therapy With a New Twist

Lin, H.; Song, P.; Zhao, Y.; Xue, L-Jia.; Liu, Y.; Chu, C-Qiu., 2016:
Targeting Th17 Cells with Small Molecules and Small Interference RNA

Yamagata, T.; Skepner, J.; Yang, J., 2016:
Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases

Duan, D.; Zhang, J.; Yao, J.; Liu, Y.; Fang, J., 2016:
Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells

Pedersen, M.W.; Jacobsen, H.J.; Koefoed, K.; Dahlman, A.; Kjær, I.; Poulsen, T.T.; Meijer, P-Johan.; Nielsen, L.S.; Horak, I.D.; Lantto, J.; Kragh, M., 2016:
Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance

Parikh, S.M., 2016:
Targeting Tie2 and the host vascular response in sepsis

Campochiaro, P.A.; Peters, K.G., 2016:
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Bass, J., 2016:
Targeting Time in Metabolic Therapeutics

Apte, R.S., 2016:
Targeting Tissue Lipids in Age-related Macular Degeneration

Farnebo, L.; Shahangian, A.; Lee, Y.; Shin, J.Ho.; Scheeren, F.A.; Sunwoo, J.B., 2016:
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma

Lawrence, H.; Mawdesley, A.Elizabeth.; Holland, J.Patrick.; Kirby, J.Andrew.; Deehan, D.John.; Tyson-Capper, A.Jane., 2016:
Targeting Toll-like receptor 4 prevents cobalt-mediated inflammation

Ferguson, D.M.; Jacobson, B.A.; Jay-Dixon, J.; Patel, M.R.; Kratzke, R.A.; Raza, A., 2016:
Targeting Topoisomerase II Activity in NSCLC with 9-Aminoacridine Derivatives

Bouhlel, M.Amine.; Lambert, M.; David-Cordonnier, M-Helene., 2016:
Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression

Bhagwat, A.S.; Vakoc, C.R., 2015:
Targeting Transcription Factors in Cancer

Waugh, K.A.; Leach, S.M.; Slansky, J.E., 2015:
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Hah, N.; Sherman, M.H.; Yu, R.T.; Downes, M.; Evans, R.M., 2016:
Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer

Yin, Q.; Liu, S.; Dong, A.; Mi, X.; Hao, F.; Zhang, K., 2016:
Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling

Wang, Y.; Bu, J.; Shen, H.; Li, H.; Wang, Z.; Chen, G., 2015:
Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System

Ma, J.; Yang, L.; Ma, Y.; Wang, X.; Ren, J.; Yang, J., 2015:
Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury

Wiegering, A.; Uthe, F.W.; Jamieson, T.; Ruoss, Y.; Hüttenrauch, M.; Küspert, M.; Pfann, C.; Nixon, C.; Herold, S.; Walz, S.; Taranets, L.; Germer, C-Thomas.; Rosenwald, A.; Sansom, O.J.; Eilers, M., 2016:
Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer

Loh, E.H.; Zambrana-Torrelio, C.; Olival, K.J.; Bogich, T.L.; Johnson, C.K.; Mazet, J.A.K.; Karesh, W.; Daszak, P., 2015:
Targeting Transmission Pathways for Emerging Zoonotic Disease Surveillance and Control

Dyck, M.S.; Mathiak, K.A.; Bergert, S.; Sarkheil, P.; Koush, Y.; Alawi, E.M.; Zvyagintsev, M.; Gaebler, A.J.; Shergill, S.S.; Mathiak, K., 2016:
Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback - Exploring Different Cases of Schizophrenia

Miskowiak, K.Woznica.; Rush, A.John.; Gerds, T.A.; Vinberg, M.; Kessing, L.V., 2016:
Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin

Spence, A.; Klementowicz, J.E.; Bluestone, J.A.; Tang, Q., 2016:
Targeting Treg signaling for the treatment of autoimmune diseases

Wei, S.; van der Lee, T.; Verstappen, E.; van Gent, M.; Waalwijk, C., 2018:
Targeting Trichothecene Biosynthetic Genes

Lieske, N.V.; Tonby, K.; Kvale, D.; Dyrhol-Riise, A.M.; Tasken, K., 2016:
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors

Li, X.; Rao, X.; Cai, L.; Liu, X.; Wang, H.; Wu, W.; Zhu, C.; Chen, M.; Wang, P.G.; Yi, W., 2016 :
Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes

Maisel, D.; Birzele, F.; Voss, E.; Nopora, A.; Bader, S.; Friess, T.; Goller, B.; Laifenfeld, D.; Weigand, S.; Runza, V., 2016:
Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model

Colombo, M.; Mirandola, L.; Reidy, A.; Suvorava, N.; Konala, V.; Chiaramonte, R.; Grizzi, F.; Rahman, R.Layeequr.; Jenkins, M.R.; Nugyen, D.D.; Dalhbeck, S.; Cobos, E.; Figueroa, J.A.; Chiriva-Internati, M., 2016:
Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis

Zhang, W.; Zhang, S-Lin.; Hu, X.; Tam, K.Yip., 2016:
Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?

Navarro, P.; Bueno, M.J.; Zagorac, I.; Mondejar, T.; Sanchez, J.; Mourón, S.; Muñoz, J.; Gómez-López, G.; Jimenez-Renard, V.; Mulero, F.; Chandel, N.S.; Quintela-Fandino, M., 2016:
Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics

Decourt, B.; Lahiri, D.K.; Sabbagh, M.N., 2016:
Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease

Alexiou, G.A.; Tsamis, K.I.; Kyritsis, A.P., 2016:
Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas

Oberoi, R.; Schuett, J.; Schuett, H.; Koch, A-Kathrin.; Luchtefeld, M.; Grote, K.; Schieffer, B., 2016:
Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion

Miao, L.; Liu, Q.; Lin, C.Michael.; Luo, C.; Wang, Y.; Liu, L.; Yin, W.; Hu, S.; Kim, W.Y.; Huang, L., 2016:
Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors

Cheetham, A.G.; Keith, D.; Zhang, P.; Lin, R.; Su, H.; Cui, H., 2017:
Targeting Tumors with Small Molecule Peptides

Azvolinsky, A., 2016:
Targeting Tumors' Energy Needs

Soule, E.E.; Bompiani, K.M.; Woodruff, R.S.; Sullenger, B.A., 2016:
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant

Glowacki, E.M.; McGlone, M.S.; Bell, R.A., 2016:
Targeting Type 2: Linguistic Agency Assignment in Diabetes Prevention Policy Messaging

Leung, E.Lai-Han.; Fan, X-Xing.; Wong, M.Pik.; Jiang, Z-Hong.; Liu, Z-Qiu.; Yao, X-Jun.; Lu, L-Lin.; Zhou, Y-Ling.; Yau, L-Fong.; Tin, V.Pui-Chi.; Liu, L., 2016:
Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation

McMullen, A.M.; Katz, M.H., 2016:
Targeting Unmet Social Needs-Next Steps Toward Improving Chronic Disease Management

Uchida, S.; Chang, W.Xiu.; Ota, T.; Tamura, Y.; Shiraishi, T.; Kumagai, T.; Shibata, S.; Fujigaki, Y.; Hosoyamada, M.; Kaneko, K.; Shen, Z.Yang.; Fujimori, S., 2016:
Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis

Anonymous, 2016:
Targeting VEGF Remodels the ECM in Colorectal Cancer Liver Metastases

Hamilton, J.L.; Nagao, M.; Levine, B.R.; Chen, D.; Olsen, B.R.; Im, H-Jeong., 2017:
Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain

Amadio, M.; Govoni, S.; Pascale, A., 2015:
Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development

Gao, Y.; Liu, X.; Li, C.; Peng, Y.; Yang, J.; Wang, X.; Li, X., 2016:
Targeting VEGF siRNA transfection by new polymeric liposomes to inhibit retinal neovascularization

Edwards, S.L.; Poongavanam, V.; Kanwar, J.R.; Roy, K.; Hillman, K.M.; Prasad, N.; Leth-Larsen, R.; Petersen, M.; Marušič, M.; Plavec, J.; Wengel, J.; Veedu, R.N., 2016:
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition

Semerano, L.; Duvallet, E.; Belmellat, N.; Marival, N.; Schall, N.; Monteil, Mëlle.; Grouard-Vogel, Géraldine.; Bernier, E.; Lecouvey, M.; Hlawaty, H.; Muller, S.; Boissier, M-Christophe.; Assier, E., 2016:
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis

Xu, W.Wen.; Li, B.; Lam, A.K.Y.; Tsao, S.Wah.; Law, S.Y.K.; Chan, K.Wah.; Yuan, Q.Ju.; Cheung, A.L.M., 2015:
Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy

Mossello, E., 2016:
Targeting Vascular Risk Factors in Older Adults: From Polypill to Personalized Prevention

Varshney, K.R.; Chen, G.H.; Abelson, B.; Nowocin, K.; Sakhrani, V.; Xu, L.; Spatocco, B.L., 2015:
Targeting Villages for Rural Development Using Satellite Image Analysis

Colpitts, C.C.; Verrier, E.R.; Baumert, T.F., 2016:
Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections

Wang, W.; Peppelenbosch, M.P.; Pan, Q., 2016:
Targeting Viral Polymerase for Treating Hepatitis E Infection: How Far Are We?

Heaton, N.S.; Moshkina, N.; Fenouil, R.; Gardner, T.J.; Aguirre, S.; Shah, P.S.; Zhao, N.; Manganaro, L.; Hultquist, J.F.; Noel, J.; Sachs, D.; Hamilton, J.; Leon, P.E.; Chawdury, A.; Tripathi, S.; Melegari, C.; Campisi, L.; Hai, R.; Metreveli, G.; Gamarnik, A.V.; García-Sastre, A.; Greenbaum, B.; Simon, V.; Fernandez-Sesma, A.; Krogan, N.J.; Mulder, L.C.F.; van Bakel, H.; Tortorella, D.; Taunton, J.; Palese, P.; Marazzi, I., 2016:
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection

Weydert, C.; De Rijck, J.; Christ, F.; Debyser, Z., 2016:
Targeting Virus-host Interactions of HIV Replication

Matheson, C.J.; Backos, D.S.; Reigan, P., 2017:
Targeting WEE1 Kinase in Cancer

Zhang, H.; Luo, H.; Hu, Z.; Peng, J.; Jiang, Z.; Song, T.; Wu, B.; Yue, J.; Zhou, R.; Xie, R.; Chen, T.; Wu, S., 2016:
Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation

Narayanan, K.; Erathodiyil, N.; Gopalan, B.; Chong, S.; Wan, A.C.A.; Ying, J.Y., 2016:
Targeting Warburg Effect in Cancers with PEGylated Glucose

Mathur, R.; Sehgal, L.; Braun, F.K.; Berkova, Z.; Romaguerra, J.; Wang, M.; Rodriguez, M.Alma.; Fayad, L.; Neelapu, S.S.; Samaniego, F., 2016:
Targeting Wnt pathway in mantle cell lymphoma-initiating cells